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Summary 
This study examines two aspects of the complex interaction between 
modified low density lipoprotein (LDL) and macrophages in the initiation and 
development of the atherosclerotic lesion. The first of these concerns the 
observed biological modification of LDL that leads to its subsequent 
enhanced uptake by macrophages, and the role of oiidation in that process. 
The second aspect of this thesis studies the effects of modified LDL on the 
functions of macrophages. 
Studies on the oxidation of LDL showed that LDL isolated from human 
plasma anticoagulated with EDTA (EDTA-LDL) was 4-fold more resistant to 
oxidation by reagent H2O2. as measured by the thiobarbituric acid (TBA) 
assay, than LDL prepared from plasma anticoagulated with citrate (CDP-LDL). 
m e L D L S required 1-3 m M H2O2 for maximal oxidation by this assay, and 
ED50S were 1.7 x 10"3 M for EDTA-LDL and 4.5 x 1(H M for CDP-LDL. 
Oxidation was enhanced 2.3-fold by Cu2+ ions. Rabbit endothelial cell line 
monolayers released three orders of magnitude less H2Q2 than was required 
to oxidize LDL and failed to induce TBA reactivity in either EDTA-LDL or 
CDP-LDL after a 24-hour coincubation. However, this LDL was subsequently 
degraded by mouse macrophages more rapidly than untreated LDL. Freshly 
isolated human monocytes (2 x 106 cells per ml), with or without phorbol 
myristate acetate (100 ng/ml) to trigger the respiratory burst, did not 
oxidize LDL in the TBA assay, despite producing large amounts of reactive 
oxygen intermediates. EDTA-LDL, CDP-LDL, and acetoacetylated LDL failed to 
trigger H2O2 release from human monocytes or macrophages. These results 
separate oxidation of LDL as measured by TBA assay from the modification 
of LDL by a rabbit aortic endothelial cell line that leads to its subsequent 
enhanced degradation by macrophages. 
Mouse peritoneal macrophages were lipid-loaded by three regimens 
modeling loading through the scavenger receptor (Ac-LDL cells), by 
extracellular matrix-bound LDL (DS-LDL cells), and conditions of reduced 
cholesterol acceptors in the medium (LS/01 cells). Increased cholesterol 
levels in all three regimens were measured by cholesterol determination, Oil 
Red 0 staining of fixed cells, and extraction of Oil Red 0 from cells and 
determination of OD530. Lipid-laden cells were equal to control macrophages 
in binding and ingesting immunoglobulin-coated sheep erythrocytes, 
reflecting Fc-mediated endocytosis. Cellular proteins appeared largely 
unchanged, but alterations in the secreted protein profile were observed by 
metabolic labeling with 35s-methionine. DS-LDL loaded cells and LS/01 
loaded cells showed increases in a 68 kD protein, and decreases in apo E 
secretion. Ac-LDL loaded cells showed significant enhancement in apo E 
secretion. The lipid-laden cells were compared to control cells for three 
secretory functions of macrophages that could be important in the 
atherosclerotic plaque. They were still capable of producing all secretory 
products examined, but the quantities of H2O2 and arachidonic acid 
metabolites are reduced in some cases, and plasminogen activator appeared 
to be increased. However, w e have lipid-loaded the cells for only two days, 
and foam cells in vivo may be exposed to these conditions for months or 
years. 
The different loading regimens result in different changes, which w e 
have separated, but in vivo the cells would be exposed to a complex mixture 
of native and biologically modified LDL, and LDL complexed 
glcosaminoglycans and with proteins of the extracellular matrix. It is 
premature to predict what changes in the macrophage's large repertoire 
would occur in vivo. 
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Chapter 1 Introduction 
General Introduction 
Arteriosclerosis is a progressive disease that is the cause for half the 
deaths in this country every year (1). It consists of a plaque in the wall of a 
large muscular artery and is characterized by the proliferation of smooth 
muscle cells (SMC), accumulation of lipids and extracellular matrix materials, 
as well as the presence of lipid-laden foam cells, necrotic debris, and a 
fibrous cap (2). This lesion can occlude blood flow to the heart or brain, 
causing heart attack or stroke. Risk factors for the disease include 
hypertension, high blood cholesterol levels, smoking, diabetes mellitus, 
obesity, lack of exercise, stress, oral contraceptives, and a family history of 
the disease (3). A major research focus is the pathogenesis of its initiation 
and development. 
Some studies of the plaque propose a model of atherosclerosis as a 
benign SMC neoplasm. This model is supported by: observations of a 
monoclonality of glucose-6-phosphate dehydrogenase isoforms in arterial 
tissue (4,5); the isolation from arterial tissue of viruses (6) and an oncogene 
activity that can transform NIH 3T3 cells (7); and the demonstration of 
elevated platelet-derived growth factor B chain (the sis gene) gene 
transcripts in atherosclerotic lesions (8). Taken together, these findings (4-
11) describe a very interesting theory which may add to our understanding 
of the factors involved in plaque development. The monoclonal theory has 
not, however, accounted for the development of the fatty streak into an 
advanced plaque, or explained how some fatty streaks may regress. 
z 
The more widely-held interpretation of the progression of 
atherosclerosis focuses on the hyperlipidemia and the interaction of the cell 
types in the artery wall (3,12-14). Poole and Florey (15) showed inl958 that 
in the hypercholesterolemic rabbit the monocytes migrate under the 
endothelium and begin to accumulate lipid there. A number of subsequent 
studies have followed the condition of arteries of animals such as swine. 
rabbits, and monkeys during a period of high dietary fat intake, and a clear 
picture has started to emerge of the sequence of events leading to the 
development of the fatty streak. 
The regular "cobblestone" appearance of endothelial cells (EC) from 
the arteries of control monkeys can be altered after only 12 days on an 
atherogenic diet. Faggiotto and Ross report the first observed change is an 
increased monocyte adherence (16-19). Several chemoattractants for 
circulating monocytes may be produced in the artery wall. These include 
platelet factor 4, which is released from platelet granules after adherence to 
the EC matrix (20); both macrophages and SMC in culture (21); and a factor 
from lesion-prone areas of swine arteries (22). Subsequent monocyte 
migration under the EC into the artery is followed by monocyte accumulation 
of lipid and results in a bumpy appearance in the lumen of the vessel. The 
continuing process of monocyte infiltration and lipid-loading has been shown 
to result in fatty streak formation (16-19). 
Gerrity has reported that the fatty streak lesion is reversible, 
depending on the number of circulating monocytes that penetrate the area. 
Degenerating foam cells have been observed in the spleen and liver; this 
provides evidence for the idea that monocytes are scavenging lipid in the 
fatty streak and then leaving the lesion, taking the lipid away (23-26). 
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Escaping foam cells or their hazardous products may damage the EC, 
resulting in the observed disruption of the EC layer, which exposes the lipid-
laden cells and the EC matrix to the bloodstream. The matrix is a site for 
platelet and LDL adherence (27.28). Thus the damage to the EC exposes the 
S M C to platelet-derived growth factor (PDGF), resulting in S M C migration and 
proliferation in the lesion (29-31). The proliferation of S M C narrows the 
lumen of the artery. PDGF-like growth factors can also be produced by the 
stimulated monocyte (32,33) (which also produces a growth factor for 
fibroblasts; 34-38), and by EC (39) and SMC (40). PDGF production by S M C is 
develop mentally regulated (41). and in a variety of cells has been shown to 
accompany transformation (42). Besides stimulating SMC growth. PDGF is 
chemotactic for monocytes and neutrophils (43) and can also lead to their 
activation (44,45). PDGF is also reported to act as a vasoconstrictor (46). 
The macrophage is the source of other mediators that produce potent 
effects in the artery wall, including interleukin-1 (IL-1) and tumor necrosis 
factor (TNF; 47). TNF and IL-1 share many activities (47,48) and their 
independent regulation results in a variety of functions. IL-1 regulates T 
lymphocytes and stimulates fibroblast growth and collagenase production 
(49,50). It induces an overall procoagulant state in endothelial cells (51-53), 
and has been reported to stimulate monocytes to be tumoricidal (54), and 
perhaps more activated for other functions. 
TNF was originally discovered in the sera of BCG- (Bacille Calmette-
Guerin) infected mice that had been injected with LPS (55). and the major 
cellular source may be activated macrophages (56). It can act as a growth 
factor for fibroblasts (57) and it also results in overall procoagulant activity 
(48,58), similar to the effects of IL-1. These changes in the artery wall could 
lead to progression of the plaque. 
4 
The fibrous cap that develops over the site confines the cells and their 
interacting products, the progressively accumulating lipids, the foam cells, 
and the proliferating SMC. This pathological lesion is the interaction of EC, 
SMC, platelets, and macrophages in close proximity, surrounded by LDL 
cholesterol. The complexity of influences is hard to overestimate. Each cell 
type present—EC, SMC, macrophage, and platelet—can secrete growth and 
inhibitory factors, vasoactive products of arachidonic acid metabolism, and 
chemotactic factors that the others may respond to by proliferation, 
chemotaxis, or the release of other bioactive mediators. The numerous 
cellular interactions in the atherosclerotic plaque have recently been 
reviewed by Ross (2). In addition, many studies have shown that EC, SMC, 
and circulating leukocytes can modify LDL for its subsequent enhanced 
uptake and degradation by tissue macrophages, contributing to the 
formation of foam cells at the fatty streak stage (59-67). 
From this complex lesion, w e have chosen to concentrate on two 
aspects of macrophage-LDL interaction. The first is the biological 
modification of LDL by EC, SMC, and macrophages that has been shown to 
accelerate macrophage foam cell formation (Chapter 3). The second aspect to 
be considered in this thesis is the effect of modified LDL on macrophage 
functions (Chapter 4). 
The Fatty Streak, Monocytes, and LDL 
Some quantitative assays are available to measure the amount of LDL 
localized in the artery wall of hyperlipidemic animals or patients. The largest 
proportion of LDL in the body (40%) goes immediately to the liver (68,69). In 
the case of acetylated LDL (Ac-LDL), 80% of the injected material appears in 
5 
the liver with a tj/2 equal to 10 minutes. The labeled Ac-LDL is recovered 
mainly in the endothelial cells at 1 hour after its injection, and subsequently 
is located in hepatocyes (70). Smith and Staples found that in human aortas 
LDL achieves almost twice as high a concentration in the inner intima (next 
to the endothelium) as in plasma, and that the internal elastic lamina 
excludes LDL almost totally although allowing passage of smaller proteins, 
including albumin (71). However, a damaged internal elastic lamina allows 
LDL to build up in that region of the artery. Intact endothelium is necessary 
to maintain the 2-fold higher LDL concentration in the intima as compared to 
the plasma (72). In agreement, Minick et al find that lipid accumulates in 
rabbit arteries more in areas of re-endothelialization than in denuded areas 
(73). Smith and Staples also report that the LDL in the intima is mainly not 
complexed with extracellular matrix since it is freely diffusable. 
Measurement of the movement of 1251-labeled LDL through rabbit thoracic 
aorta in vivo shows that LDL passes into the artery rapidly and from both 
the lumenal and adventitial sides. LDL accumulates less in the media, and 
1251-LDL decreases gradually over 67 hours (74). 
Analysis of total lipids from fatty streaks shows 95% cholesterol 
esters, and of these 50.4 % were esterified with oleic acid. After isolation of 
lipid droplets from the fatty streak, the residual tissue fraction was found to 
have a lipid composition very similar to normal intima (75). Examination of 
the apoproteins from mild and severe sclerotic plaques revealed LDL in 
human aortic intima in complexes with mucopolysaccharides (or 
glycosaminoglycans, GAGs) and sulfated polysaccharides (76). Bihara-Varga 
and Vegh (28) showed that GAGs selectively bind serum lipoproteins with 
the composition of LDL, that these GAG-LDL complexes form in the presence 
of calcium and that they could be isolated only from atherosclerotic aortic 
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intimas and not from normal aortas. In fact, increased amounts of GAGs, in 
particular chondroitin sulfate C, can be isolated from aortas of very early 
lesions, even the fatty streak (77). Dalferes et al suggest that the presence of 
GAGs in the intima. considering that they form insoluble complexes with LDL, 
could be a mechanism for lipid accumulation and sequestration in the artery 
wall. This mechanism could probably only operate during the fatty streak 
stage, since aortic chondroitin sulfates are reported to decrease with the 
advancement of disease (78). Lipoprotein-GAG complexes have also been 
isolated from rabbit aortic lesions, although those complexes are GAG-VLDL, 
as VLDL is the most common lipoprotein in rabbit plasma (79). The presence 
of an intact endothelium allows more GAG accumulation. Chondroitin sulfate 
A/C and heparan sulfate (but not dermatan sulfate) build up in the intima of 
re-endothelializing rabbit aortas (80). 
Gerrity has shown in swine that the initial AS lesion, the fatty streak, 
consists of blood monocytes that have entered a lipid-engorged vessel of a 
hypercholesterolemia animal and become foam cells (23-26). Electron 
microscopic data form the basis of the conclusion that the lipid-laden 
macrophage foam cells return through the endothelium into the bloodstream. 
Medial S M C are not involved in the fatty streak lesion. In the aortic arch of 
swine the lesions do not develop beyond the fatty streak stage although 
fibrous lesions develop in the same animal in the abdominal aorta. Gerrity 
suggests that these fatty streak lesions do not progress further precisely due 
to the presence of a peroxidase-positive monocyte "lipid-clearance system." 
Perhaps, as has been suggested, the exiting foam cells might disrupt the EC 
integrity, resulting in the open lesions (16-19) that allow lipid and other 
plasma factors, including platelets, access to the SMC. 
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H o w do monocytes clear away the LDL and LDL-GAG complexes? 
Macrophages have the classical LDL receptor as described in fibroblasts by 
Brown and Goldstein (81,82). It is a high-affinity membrane receptor that 
binds LDL saturably and leads to its internalization by receptor-mediated 
endocytosis. The LDL degradation products regulate the cholesterol 
metabolism of the cell. High LDL levels decrease the synthesis of LDL 
receptors, and suppress the activity of 3-hydroxy-3-methylglutaryl 
coenzyme A reductase, the rate-limiting enzyme in cholesterol synthesis. 
LDL's cholesterol increases cellular cholesterol esterification (esters being the 
preferred storage form) by acyl-CoA:cholesterol acyltransferase (ACAT). 
Macrophages also bind chemically modified LDL, i.e. acetylated, 
maleylated, acetoacetylated, succinylated, or malondialdehyde-treated (83-
95). In human monocyte-derived macrophages the modified LDL receptor is 
not very active before 5 days of culture (88,89). The modifications of LDL 
change the epsilon amino groups of lysine to a more negatively charged form 
(90,91). Modified LDL might be formed in vivo by reaction with the platelet 
products malondialdehyde (85) or 4-hydroxynonenal (92) or by other 
metabolites of arachidonic acid, including 5-HPETE or leukotriene A4(82). 
LDL complexed with this array of negatively charged compounds competes 
with maleylated albumin (mal-BSA) and with the sulfated polysaccharides 
fucoidin and dextran sulfate for binding to the "modified LDL" or scavenger 
receptor (84.91). It has been speculated that this negative charge confers a 
conformational change on the apoprotein, since de-maleylated BSA still 
competes for binding with mal-BSA (93). It should be pointed out that 
monocytes express both the mal-BSA receptor and the scavenger receptor, 
and that the mal-BSA receptor is a chemoattractant receptor (94,95). 
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Uptake of acetylated LDL (Ac-LDL) or other modified forms of LDL 
through the macrophage scavenger receptor occurs at 20 times the rate of 
LDL uptake through the native LDL receptor and stimulates cholesterol 
esterification, resulting in enormous cholesterol ester accumulation (84-86). 
The scavenger receptor of mouse macrophages has 20,000-40,000 binding 
sites per cell and is protease sensitive. Binding is not dependent on divalent 
cations and reaches half-maximal at 25 ug LDL/ml at 37°C (82). The purified 
Ac-LDL receptor from mouse macrophage tumors has a M r of 260,000 
daltons. The receptor has a Kd of 3.1 x 10"* M~* (96). 
Unlike the native LDL receptor which is found in coated pits in the 
macrophage cell membrane, the scavenger receptor is distributed more 
diffusely over the cell. The receptors do cluster after ligand binding but not 
in coated pits (97), and are reported to recycle more rapidly than the native 
receptors (98). The activity of the scavenger receptor can be suppressed by 
lymphocyte products (99,100), bacterial endotoxin (101), and a platelet 
secretory factor (102). 
SMC are also exposed to LDL in the artery wall, and they also degrade 
LDL with subsequent reduction in cholesterol synthesis, but do not take up 
Ac-LDL avidly (103,104). However, they are subject to a variety of 
influences. Under hypoxic conditions SMC LDL uptake was increased, but 
degradation was decreased 36%. This could lead to accumulation in the 
artery (105). Macrophage conditioned medium increases SMC cholesterol 
esterification—perhaps, if Ac-LDL is present, by changing the lipoprotein 
lipid balance (106), or by way of a secretory product (107). Platelets are also 
reported to enhance cholesterol accumulation in SMC (108). 
In the normal rabbit aorta, 16% of the LDL degradation is mediated by 
the intimal EC LDL receptor (69). H u m a n umbilical artery and vein EC in 
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culture also have a high affinity LDL receptor accounting for 17% of the total 
LDL endocytosis at physiological LDL concentrations (109,110). Like 
macrophages. EC have a scavenger receptor and take up Ac-LDL more 
rapidly than native LDL (104,111). Additionally, in the experiments reported 
by Stein and Stein, confluent EC degraded more Ac-LDL than did 
subconfluent cultures, the opposite of the finding for LDL degradation by EC 
cultures. Pitas et al report liver sinusoidal EC have a Kd of 2.5 x 10-9 M"1 for 
modified LDL (111). Aortic EC degrade less than 1 % of the Ac-LDL degraded 
by liver EC (112). 
EC receptors, native or scavenger, are not the only mode of entry of 
LDL into the artery wall. The bulk of the LDL enters the cell through low 
affinity adsorptive endocytosis (111). LDL might also enter the artery wall 
by accompanying migrating monocytes, as shown by Territo et al (113). 
LDL that has been exposed to EC, SMC, or macrophages in culture has 
been shown to be modified for enhanced degradation by a non-LDL 
receptor-mediated mechanism. Biologically modified LDL competes with 
chemically modified LDL for binding to the scavenger receptor (59-67). A 
similar modification of LDL is observed from LDL re-isolated from human 
aortas or rabbit aortic interstitial fluid (114-118). Thus, the biological 
modification may contribute to accelerated foam cell formation. The 
mechanisms postulated to underlie the cell-mediated modification of LDL 
include oxidation, lipolysis, and proteolysis, but in no instance has this 
alteration been clearly defined in molecular terms. In light of our interest in 
foam cell formation, w e pursued the oxidative modification of LDL by a 
detailed study of a major oxidizing secretory product of phagocytic cells, 
H2O2. In chapter 3, w e report the susceptibility of LDL to oxidation by known 
concentrations of chemical oxidants, by EC. and by the diverse group of 
reactive oxygen intermediates produced by monocytes. In addition, w e have 
investigated the ability of monocytes and macrophages to respond to 
modified LDLs by releasing H2O2. 
Foam Cells and the Atherosclerotic Lesion 
An analysis of atherosclerotic aortas reveals significant enrichment of 
catalase, acid hydrolases, and free and esterified cholesterol (119). Isolation 
of cells from these regions by enzymatic digestion results in cell populations 
that display some properties of macrophages and some of smooth muscle 
cells. Monocytes had previously been shown to become loaded with fat 
under certain culture conditions (120). Haley et al separated the total cell 
population into a high density and low density fraction on a metrizamide 
density gradient and observed that the low density fraction cells were 
particularly highly enriched in lysosomal hydrolases (121,122). Studies on 
monkeys revealed similar cell distribution and biochemical function. 
Interestingly, most of the accumulated lipid was found to be extracellular 
(123). This may be due to the compartmentalization of tissue water in the 
more advanced lesion (124). Subsequent electron microscopic studies by 
Fowler et al identified the high density cells as smooth muscle cells. The low 
density aortic cells were concluded to be authentic macrophages based on Fc 
receptors, high levels of catalase and acid hydrolases, and the ability to 
ingest antibody-coated particles. However, only one third of these cells had 
C3 receptors and they did not show the presence of lysozyme, either in 
intracellular or secreted form (125). 
Using glass adherent cells instead of enzymaticaily digested cells, 
Schaffner et al (126) confirmed the presence of macrophage-origin cells in 
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the lesion. They were able to detect C3 receptors on 80-90% of the isolated 
glass-adherent cells. And from primate aortas they measured higher 
lysozyme content than in that of the rabbit. These studies conclude that the 
atherosclerotic lesion has two lipid-loaded populations and that in fact foam 
cells derive from both S M C and macrophage cell types. 
Macrophage-derived foam cells from rabbit explants were shown to 
accumulate lipoprotein through the modified-LDL (scavenger) receptor as 
well as the p-VLDL receptor. Interestingly, Pitas et al also showed that 
explanted foam cells retained their cholesterol esters under culture 
conditions where in vitro loaded cells lost them (127). 
Lipid analysis of macrophage foam cells has been reported by Kelley 
et al from an experimentally-induced granuloma in rabbit. Macrophages 
accumulated in rabbit aortas in response to the subcutaneous injection of the 
sulfated polysaccharide carrageenan. In animals pre-loaded with a high 
cholesterol diet for 28 days, the macrophages quickly began to accumulate 
lipids, particularly cholesterol esters, reaching almost 80 times the control 
cell cholesterol ester level by 14 days, and 178 times by 28 days. Oleate 
(18:1) was the most frequently found fatty acid in the cholesterol esters, 
comprising almost 50% of those in the high-cholesterol animals (128,129). 
But the presence of foam cells is not the only difference in the 
advanced atherosclerotic lesion. Normal carotid artery and aortic cell 
populations are altered (130,131). Serial sections of the mature AS plaque 
tissue from human carotid artery extensively analyzed with monoclonal and 
polyclonal antibodies directed against specific cell lineages showed that 60% 
of the cells in the necrotic core of the lesion are Leu-M3 positive, 
representing macrophages, as are 2 4 % of the cells in the fibrous cap. 
Conversely, 60% of the cells in the fibrous cap are des min positive, 
representing SMC, and only 29% of the cells in the core. Interestingly, the 
Leu 4 antibody marking T lymphocytes stained 20% of the cells in the 
fibrous cap, but almost none in the necrotic core or the surrounding areas of 
artery. T ceils are almost absent from normal arteries. Of the T cells 
identified, almost 3 times as many T4+ (helper) cells are present as T8+ 
(suppressor) cells. S M C from plaques express HLA-DR, a class II 
transplantation antigen generally found only on ceils of the immune system 
(132). This phenotypic change suggests the presence of IFfy, a cytokine 
known to increase la on SMC and other cell types (133). This surface marker 
may reflect other functional changes in the SMC, and, in combination with 
the presence of the T4+ lymphocytes, suggests active participation of an 
immune reaction in the artery. 
McCullagh et al have shown that the distribution of collagen types in 
the atherosclerotic human aorta is different from that in uninvolved areas. 
The SMC collagen, type I, is increased in plaques, representing a functional 
shift for the cells. Type I collagen forms thick bundles, resulting in more 
rigidity and less elasticity in that section of the artery. These features could 
be very important in the progression and pathology of the disease (134). 
Analysis of the lipid composition of advanced plaques from human 
carotid and femoral arteries also revealed enormous changes from the 
normal artery. LDL has been immunocytochemically localized by use of 
antibodies to the apoprotein B. Areas of diseased human aortas (but not 
normal aortas) were shown to have extracellular LDL in the necrotic core of 
an advanced plaque, lining the internal elastic lamina and surrounding the 
SMC. All macrophages were negative for apo B, even though some foam cells 
were surrounded by it (135). Yomantas et al showed that highly lesion-
prone areas also reflect intracellular apo B, not seen in less severe lesions 
(136). Over 50% of the cholesterol in the advanced lesion was in a free, 
unesterified form. In normal artery, the fatty streak lesion, or a xanthoma. 
only 25% of the total cholesterol was unesterified. The plaques esterified 
cholesterol had a ratio of 1.7 of linoleic/oleic acid as the fatty acid esterified, 
compared to a ratio of 0.36 (linoleic/oleic) in xanthomas. These differences 
are important because they allow conclusions about the location of 
cholesterol esterification. The plasma enzyme LCAT uses predominantly 
linoieic acid, and ACAT, the macrophage esterifying enzyme, uses 
predominantly oleic. The increase in ratio of linoleic/oleic from 0.36 to 1.7, 
combined with the high level of free cholesterol, implies a failure of the 
macrophages within the lesion to keep up with lipid metabolism. Rapp et al 
speculate that this "decreased metabolic efficiency" of the macrophages may 
enhance plaque progression (137). The reduced cholesterol ester proportion 
can also be observed from the predominance of isotropic forms of lipid 
droplets in more advanced lesions (75). 
W e have seen from the literature that the monocytes initially 
migrating into the artery at the time of fatty streak formation may meet 
native LDL, biologically modified forms of LDL, and LDL-GAG complexes. 
They have been shown to ingest and accumulate lipid, maintaining a high 
proportion of cholesterol esters, and using oleic acid primarily in the 
formation of the cholesterol esters. But in advanced lesions, the monocyte-
derived foam ceils seem unable to metabolize the volume of lipid, which 
leads to an increase in the proportion of free cholesterol, and to a change in 
the cholesterol ester profile from oleic to linoieic as the fatty acid esterified. 
Also as the fatty streak progresses to the advanced lesion, smooth muscle 
cells proliferate and become lipid-loaded foam cells. The plaque is very 
different from the normal artery wall or even the fatty streak, and a 
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possible contributing factor is the reduced capacity of the macrophage 
scavenging system. This may be due to impairment of the macrophages' 
metabolic functions after lipid loading. 
Several investigators have reported reductions in macrophage 
functions as a result of interaction with lipid. Chapman and Hibbs have 
shown that macrophage tumoricidal activity is reversibly inhibited by 
incubation with LDL (or an LDL-associated component) and that an increase 
in cholesterol content of the plasma membrane inhibits cytocidal activity and 
the ability of the cells to respond to endotoxin stimulation (138). An increase 
in the saturation of the plasma membrane phospholipids of the macrophage 
has been shown to decrease the rates of, and increase the energy 
requirements for, pinocytosis and phagocytosis (139). Accumulation of 
polyanions, like the GAGs prevalent in the artery wall, inhibits lysosome-
phagosome fusion and decreases lysosomal membrane fluidity (140). 
Macrophage lysosomes are critical for digestion of scavenged debris or 
microorganisms (141). 
Ligands of the scavenger receptor have been shown to trigger 
secretory functions of the cell (142). The chronic stimulation by modified-
LDL ingestion could make the cells refractory to additional signals, or result 
in toxicity to the cell. Foam cells may suffer membrane lipid peroxidation or 
other physical changes due to the large lipid pools within them. The effect of 
lipid-loading on macrophage functions is an important issue which has not 
been addressed. W e will report on the capabilities of the lipid-laden cell in 
Chapter 4. 
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Chapter 2 Materials and Methods 
LDL Preparation and Modifications 
Preparation of LDL. LDL was prepared as indicated from human 
plasma anti-coagulated with either EDTA (5 m M , final concentration) or CDP 
(1.61 g of sodium citrate dihydrate/ 0.19 g of anhydrous citric acid/ 0.14 g 
of disodium phosphate/ 63 ml of water for 450 ml blood). Isolation of LDL 
was as in ref. 143 with modifications as follows: 100 ml of freshly drawn 
blood from healthy volunteers was centrifuged at 850 x g for 15 min at 25 
°C. The separated plasma was then centrifuged at 1300 x g for 15 min at 4 °C 
to remove platelets. The density of the plasma was adjusted with KBr and 
11.5 ml of the solution was pumped under 27.5 ml saline in heat-sealing 
tubes (Beckman). The tubes were centrifuged in a VTi 50 vertical rotor at 
45,000 rpm, 4 °C, for 3 hr, using a computerized slow acceleration and 
deceleration program (Beckman #9). LDL was harvested; its density was 
increased to 1.1 g/ml using KBr; and then it was centrifuged in Ca2+/Mg2*-
free Dulbecco's phosphate-buffered saline (PD; GIBCO), at a density - 1.100 
(adjusted with KBr), for 18 hr in a Beckman Ti 70 rotor at 40,000 rpm at 4 
°C. This diminished the albumin contamination after the vertical rotor step. 
The resulting LDLs were called EDTA-LDL (LDL isolated from plasma anti-
coagulated with EDTA) and CDP-LDL (LDL isolated from plasma anti-
coagulated with citrate). 
EDTA-LDL was dialyzed against PD that contained 0.01% (0.26 m M ) 
EDTA (61). CDP-LDL was dialyzed against PD alone, which was continuously 
sparged with N2 to prevent oxidation. Dialysis was at 4 °C in 50-100 times 
the sample volume, for each of three changes of buffer over 12 hr. Dialysis 
Figure 2-1. Preparation of LDL from plasma. Human plasma was anti-
coagulated with EDTA or CDP. 11.5 ml of density-adjusted plasma was 
layered under sterile saline (A) and centrifuged for 3 hr as described in 
methods. LDL is the yellow band in the center of the tube shown in B. LDL 
was harvested, its density was adjusted to 1.1 g/ml with KBr (C) and was 
centrifuged again for 18 hr. The final product is shown in D. 
Figure 2-1 
Preparation of LDL from Human Plasma 
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Figure 2-2 
Purification of LDL from Plasma 
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Lane A plasma 
Lane B LDL after VTi 
Lane C LDL after Ti70 
Figure 2-2. 3-10% gradient SDS Page of purification of LDL. 15 jug of 
protein was loaded per lane. The gel was stained with Coomassie blue stain. 
Lanes are as labeled. 
tubing was of 12,000-14,000 M r cutoff (Spectrapor 2, Spectrum Medical 
Industries, Los Angeles). LDLs were stored in acid-washed glass tubes under 
N2. EDTA-LDL was prepared freshly every two weeks, and CDP-LDL was 
prepared every week. All LDLs were examined for purity by 3-10% 
SDS/polyacrylamide gradient gel electrophoresis (adapted from ref 144) 
before use. EDTA-LDL was iodinated (carrier-free Nal25i, New England 
Nuclear) by the method of Bilheimer et al (145) to a specific activity of 400-
500 cpm/ng. Protein was determined by the method of Lowry (146). 
Acetylation (Ac-LDL) and Acetoacetylation (AcAc-LDL). EDTA-
LDL was modified by diketene according to the method of Weisgraber et al. 
(147). The extent of acetoacetylation was measured by reaction with 2,4,6-
trinitrobenzenesulfonic acid (Pierce) in the spectrophotometric assay of 
Fields (148), as well as by 1% agarose gel electrophoresis, using a barbital 
buffer system at pH 8.6 (149). Each modification was accompanied by a 
mock-modified control. 
EDTA-LDL was acetylated by repeated additions of acetic anhydride 
while stirring in an ice water bath, following the method of Basu et al (149). 
Ac-LDL was dialyzed as described for EDTA-LDL before use in experiments. 
Extent of acetylation was determined by agarose gel as described above. 
Dextran Sulfate LDL (DS-LDL) Complexes. LDL was complexed 
with dextran sulfate according to the method of Kielian and Cohn (140). As 
described, LDL and dextran sulfate were combined in an equal weight ratio 
and then CaCl2 was added to 0.1 M final concentration. DS-LDL was stored at 
4 °C overnight and then pelleted, washed 3x with double distilled water at 
4 °C, and resuspended tol mg/ml LDL in M-10 culture medium (see below). 
The mobility of DS-LDL complexes in an agarose gel is shown in Figure 2-3. 
Figure 2-3 
1% Agarose gel of LDL, Ac-LDL, DS-LDL 
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Figure 2-?>. I % Agarose gel of LDL, Ac-LDL, and DS-LDL. 15 ug of 
protein was loaded per lane, and the gel was stained with Coomassie blue 
stain. Lanes A, D, K: LDL. Lanes B, C, E, F, G: Ac-LDL. Lanes H, I, J: DS-LDL. 
The variations in band patterns from different preparations may be due to 
size heterogeneity of the dextran sulfate. 
H 2 0 2 Oxidation of LDL. LDL (ca. 100 jug) was diluted to 0.5 ml in 
serum-free H a m s F-10 medium (Flow laboratories) and was incubated for 3 
hr at 37 °C in covered glass tubes with H2O2 (Fisher) and other reagents as 
described in chapter 3. Catalase (300 U/mi) was added for 15 min at 37 °C 
before the samples were tested, because H2O2 inhibits the TBA assay by 
37.5% at concentrations of 1 m M , and by 100% at 0.1 M. Samples were tested 
by agarose and SDS gel electrophoresis and in duplicate by the TBA assay 
(see below). 
Endothelial Cell Modification of LDL (Ec-LDL). EC-LDL was 
prepared as described by Steinbrecher et al (61), using the same cell line 
and medium. LDL at 100 jug/ml was incubated at 37 °C in a humidifed 
atmosphere of 95% air/5% CO2 with confluent monolayers of EC (see below) 
or serum-washed cell-free flasks in serum-free H a m s F-10 supplemented 
with penicillin at 100 units/ml, streptomycin at 100 jjg/ml, and glutamine at 
300 jug/ml. Our use of 25 cm 2 flasks resulted in the same ratio of volume of 
medium to cell culture surface area as for the petri dishes used in ref. 61. 
After 24 hr, medium was collected, centrifuged at 300 x g for 10 min to 
remove cellular debris, and then tested by agarose gel electrophoresis and in 
duplicate in the TBA assay. 
Cell Culture 
Endothelial Cells (EC). A continuous line of rabbit thoracic aorta EC 
was obtained from V. Buonassissi (W. Alton Jones Cell Science Center, Lake 
Placid, NY). Cells were incubated at 37 °C in a humidifed atmosphere of 95% 
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air/5% CO2, in 25-cm2 tissue culture flasks (Corning) in Ham's F-l2 medium 
(Gibco) supplemented with 10% (v/v) fetal bovine serum (FBS; Hyclone, 
Logan, UT), glutamine, penicillin, streptomycin as above. Medium was 
changed twice per week, and cells were passaged once per week, using 0.25% 
trypsin (Flow laboratories) in 1 m M EDTA. The cells were mycoplasma-free 
as tested by fluorescent bisbenzimide staining (Hoechst 33342; Aldrich). 
H u m a n Monocyte/ Macrophage Culture. Cells were isolated from 
human peripheral blood or buffy coat using a Ficoll/Hypaque gradient 
(Pharmacia) as described (150), and cultured in RPMI 1640 (KC Biologicals, 
Lenexa, KS) with glutamine, penicillin, and streptomycin as above, and 25% 
(v/v) human serum. Cells were incubated for 2 hr to allow adherence, then 
nonadherent cells were rinsed away and culture medium was replaced (day 
0). Medium was changed again on days 1 and 4. Recombinant human X 
interferon (Genentech, South San Francisco) at 100 antiviral units/ml was 
added on day 4. Cells were assayed for H2O2 release on day 7. 
Mouse Peritoneal Macrophage and Foam Cell Culture. Cells 
were isolated by peritoneal lavage of specific pathogen-free female ICR mice 
(Trudeau Institute, Lake Placid, NY.) weighing 25-30 g, as previously 
described (151). Peritoneal cells (8 x 106) in minimal essential medium 
(MEM) supplemented with 10% (v/v) FBS and antibiotics and glutamine as 
above (M-10) were added to 35-mm plastic tissue culture dishes (Nunc, 
InterMed, Denmark) or at 1 x 106 to 13 m m acid-washed glass coverslips 
(Gold Seal 3550). Cells were incubated for 2 hr to allow adherence, 
nonadherent cells were rinsed away and culture medium was added (day 0). 
Medium with all additions was replaced daily. 
Foam cells were prepared by addition of lipoproteins to M-10 as 
follows: 
1. M-10 with 200 jug/ml Ac-LDL. called Ac-LDL macrophages. 
2. M-10 with 10 jug/ml DS-LDL. called DS-LDL macrophages. 
3. M E M with antibiotics and gentamycin and 1% FBS (v/v; M-l) with 200 
ug/ml Ac-LDL and 20 u M BSA and 100 juM oleic acid, called Low serum/Oleic 
(LS/01) macrophages. 
Assays 
H2O2 assay. Freshly isolated human mononuclear leukocytes were 
plated at 2 x 105 cells/well and assayed for H2O2 release in 96-well flat-
bottom polystyrene tissue culture plates (Corning). For monocyte-derived 
macrophages and mouse peritoneal macrophages, mononuclear cells were 
plated at a density of 1 x 106 cells perl3-mm glass coverslip. cultured, and 
assayed for H2O2 release in 24-well plates (Falcon, Becton Dickinson 
Labware, Oxnard, California). EC were plated at 1 x 10* cells per well in a 96-
well plate and were assayed 1 or 2 days later. H2O2 was assayed by 
determining the H202-dependent loss of scopoletin fluorescence using a 
Dynatech Corporation Microfluor plate reader (152). 
Thiobarbituric Acid (TBA) Assay of Lipid Peroxidation. 
Samples (100-300 jul) containing 25-30 ug of LDL protein were tested as 
described in ref. 153. Each sample was treated with 1.5 ml of 20% (w/v) 
trichloroacetic acid (TCA) followed by 1.5 ml of freshly prepared 0.67% TBA 
(Aldrich) and heated to 95 °Cfor 15 min. The amount of malondialdehyde 
formed was determined by fluorescence measured on a Perkin-Elmer MPF-
44a fluorometer (515-nm excitation, 553-nm emission wavelengths). Freshly 
diluted 1,1.3,3-tetramethoxy propane (Aldrich) served as standard. The 
assay is sensitive to 0.1 nmol of malondialdehyde. 
Cholesterol Assay. Total cellular cholesterol determination was 
made after extraction of cellular lipids by the method of Bligh and Dyer 
(154). 35 m m dishes of control macrophages or foam cells were rinsed twice 
in PD containing 2 mg/ml BSA (PD/BSA), and twice more in PD alone before 
being scraped with a rubber policeman. An aliquot of the scraped cell 
suspension was removed for protein determination and the rest was added 
to 3.75 ml chloroform/methanol 1:2 (v/v) at 4 °C, covered, vortexed, and 
allowed to stand for 10 min. 1.25 ml of chloroform was added to each sample 
followed by 1.25 ml of water, both at 4 °C. The mixture was vortexed again 
and centrifuged at 1500 rpm at 4 °C for 10 min in a Damon/IEC CRU 5000 
Centrifuge. The lower, organic phase was recovered and brought to dryness 
under a stream of N2. After drying, the samples were resuspended in 200 Jul 
chloroform/methanol and heated for 15 min at 75 °C in a heating block. 
Samples were again resuspended in 200 ul ethanol and 2 ml assay buffer 
was added to each tube before being covered and incubated in air for 30 min 
at 37 °C Fluorescence was determined using the Perkin-Elmer MPF-44a 
fluorometer, at wavelengths of 325-nm excitation, 415-nm emission. Sigma 
aqueous cholesterol standard was freshly diluted for the standard curve in 
each assay. The assay mix was as described by Gamble et al (155), using a 
peroxidase-catalyzed reaction detecting H2O2 from enzymatic cholesterol 
oxidation and producing a stable fluorescent product. 
Oil Red O Staining and Extraction. Coverslips were rinsed in 
PD/BSA and fixed in 5% formalin in PD (v/v) for 30 min. The coverslips were 
blotted, rinsed in PD, and stained in Oil Red 0 (Kodak) at 0.5% in 60% 
triethylphosphate (Kodak) for 15 min. The coverslips were rinsed in double 
distilled water, and mounted on slides with nail polish. This is a standard 
method (140). 
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For extraction and quantification of Oil Red 0 staining, fixed and 
stained coverslips were extracted in 0.8 ml dioxane. and compared to a 
dioxane blank at OD530 (156). Dioxane was selected because it resulted in a 
higher specific OD than chloroform, chloroform/methanol 1:2, or 
chloroform/methanol 2:1. 
Thin Layer Chromatography (TLC) of Foam Cell Lipids. One-
dimensional TLC to separate lipids into individual classes was done according 
to the method of Falcone et al (157), using petroleum ether/ diethyl ether/ 
acetic acid, 97:100: 3 (Mallinkrodt, chromair quality) as the first solvent 
system, and petroleum ether/ diethyl ether, 200:6, as the second solvent 
system. 35 m m dishes of control macrophages and foam cells were rinsed 3x 
in PD and extracted in situ with 2 ml/dish of hexane/ isopropyl alcohol, 3:2 
for 30 min, and then extracted again for 10 min with another 1 ml of 
hexane/ isopropyl alcohol, 3:2. The three ml were combined in an acid-
washed tube and dried under N2. Samples were resuspended in 100 jui 
chloroform/methanol 2:1 and spotted onto pre-washed and heat-inactivated 
silica gel 60 precoated TLC plates (Thomas). Plates were stained with freshly 
prepared 0.0001% rhodamine 6G in 0.25 M dibasic potassium phosphate, and 
photographed under ultraviolet light. 
Two dimensional TLC was performed on Redicoat (Supelco, Inc., 
Beliefonte, PA) heat-inactivated plates as described in ref. 158. Briefly, the 
first direction was chloroform/methanol/ammonium hydroxide, 65/25/5, 
v/v/v, and after drying the plate was turned 90 degrees and 
chromatographed in chloroform/acetone/methanol/acetic acid/water, 
33/44/11/11/5.5, v/v/v/v/v. Lipid standards were visualized with I2 
vapor, and lipid-containing regions of the plate were scraped into 
scintillation vials with 1 ml water and 10 ml aquasol (National Diagnostics 
Inc., Somerville, NJ) per sample before radioactivity was determined in a 
scintillation counter. 
Phagocytosis of Immunoglobulin G-coated Sheep 
Erythrocytes (EIgG). EIgG, sheep erythrocytes coated with rabbit anti-
erythrocyte IgG, were kindly provided by Dr. Samuel Wright. 35 m m dishes 
of control macrophages and foam cells were washed 2x in M E M before 1.5 ml 
of M E M containing 2.0 x 107 EIgG/ml was added. After 45 min of incubation 
at 37 °C in a humidifed atmosphere of 95% air/5% CO2, the dishes were 
rinsed in PD for determination of attachment index. For phagocytosis index, 
the dishes were dipped 5x in distilled water for 1 second per dip and then 
returned quickly to PD. This procedure lysed any uningested EIgG. Cells were 
fixed in 2.5% gluteraldehyde in PD (v/v), and the number of attached or 
ingested particles was counted under phase-contrast microscopy using an 
inverted microscope with a 40x water-immersion objective (159). 
Fibrinolysis by Macrophages and Foam Cells. Peritoneal cell 
suspensions were plated onto 125i-fibrin coated 24-well plates, prepared 
according to an established method (160) and provided by Drs. L. Ossowski 
and R. Mir a y Lopez. Cells were plated at 2 x 105 cells/well in M E M with 5% 
FBS, antibiotics and glutamine as above and 100 jug/ml soybean trypsin 
inhibitor to prevent fibrinolysis during culture. Nonadherent cell removal, 
lipoprotein additions, and daily culture medium changes were made as 
described for foam cells. After 48 hr of incubation, the culture medium with 
soybean trypsin inhibitor was removed, cells were rinsed with M E M and the 
fibrinolytic assay was initiated by the addition of M E M supplemented with 
5% acid-treated FBS (AT-FBS). Acid treatment of FBS inactivates serum 
plasmin inhibitors. At the time points indicated, radioactivity of triplicate 
aliquots of the supernatant was determined and variation did not exceed 
10%. The percent of the 1251-fibrin substrate solubilized was determined 
after subtraction of background counts, and is expressed per 5 x 1 0 * cells, 
based on nuclear cell counts (161) from the wells at the end of the 
fibrinolytic assay. 
35s Methionine Secreted Protein Profile. 35 m m dishes of 
control macrophages and foam cells were washed 3x with methionine-free 
RPMI-1640 and labeled with 35s-methionine (New England Nuclear) in 
methionine-free RPMI-1640 for four hr as described by Werb and Chin 
(162). After the incubation, the culture medium was collected, centrifuged 
for 3 min in an Eppendorf Microfuge, and the supernatant was transferred to 
a fresh tube. Before precipitation of proteins for 30 min on ice with 5% TCA, 
M. lysodeikticus at 2 mg/ml in normal saline was added as a carrier. Samples 
were pelleted and then washed 2x inl ml of 5% TCA, and finally 
resuspended in SDS sample buffer. After the culture medium was removed 
and the monolayer was rinsed 2x with PD, 35S- methionine labelled cellular 
proteins were harvested from 35 m m dishes by adding SDS sample buffer 
directly to the dish. Before samples were loaded on gels, they were heated to 
95 °C for 3 min and 5 Jul aliquots were removed for counting with aquasol in 
a scintillation counter. Samples were loaded onto a 7-18% gradient SDS-
PAGE, electrophoresed, and developed for autoradiography as described. 
Immunoprecipitation of Apolipoprotein E. Apolipoprotein E (apo 
E) was labelled from control macrophages and foam cells as described above 
for the 35s-methionine secreted protein profile. Goat anti-human apo E 
antiserum or control goat serum was added to the culture supernatant at 
1:100 dilution in antibody buffer (150 m M NaCl, l O m M Tris-HCl, 1% 
powdered milk). Samples were allowed to shake on the nutator at 4 °C for 2 
hr and then 50 ul of a 50% slurry of pre-cleared (with antibody buffer) 
Protein A-agarose beads (Boehringer Mannheim Biochemicals) was added, 
and samples were rotated for an additional 1 hr. Samples were pelleted by 2 
min centrifugation at highest power in a Savant High Speed Microcentrifuge. 
The resulting pellet was washed 5x with antibody buffer and then 5x with 
PD. The pellets were suspended in 50 ul SDS sample buffer containing 60 
m M dithiothreitol, heated, counted, loaded, and processed for 
autoradiography as above. 
Release of 3 B 20:4 and 20:4 Metabolite Profile. 35 m m dishes 
of control macrophages and foam cells were cultured from day 1 to day 2 
with the same lipoprotein additions as described and 0.5 JuCi 3H-20:4/dish. 
After 16 hr equilibration, monolayers were rinsed 3x with PD and 1.2 ml 
M E M was added to each dish, with or without 160 ug/ml zymosan or 10 
jug/ml of the calcium ionophore, A23187, as indicated in chapter 4. Cells 
were incubated at 37 °C in a humidifed atmosphere of 95% air/5% CO2 for 
the times indicated, and aliquots of the culture supernatant were removed 
and radioactivity was determined in aquasol in a scintillation counter. 
Monolayers were lysed in 2 x 0.5 ml 0.05% triton X-100, and portions were 
removed for determination of radioactivity or assayed for protein. 
Metabolites of 20:4 from 1 ml culture medium were extracted with 1 
ml ethanol and 10 ul 0.88% (w/v) formic acid, and then extracted twice with 
1 ml chloroform. The organic phases were combined, dried under N2, and 
resuspended in the appropriate solvent for further purification by reverse-
phase high-pressure liquid chromatography (HPLC) as described in ref. 163. 
To summarize: the 20:4 metabolite extracts were chromatographed on an 
Ultrasphere C-18 column, using methanol/ water/ acetic acid, 65: 34.9:0.1 
(v/v/v), pH 5.4, as solvent 1, followed by methanol/ acetic acid, 100:0.01 
(v/v) as solvent 2. The cyclooxygenase products were analyzed on a Waters 
fatty acid analysis column, using water/ acetonitrile/ benzene/ acetic acid, 
76.7: 23: 0.2: 0.1 (v/v/v/v) as solvent 1, followed by methanol/ acetic acid, 
100:0.01 (v/v) as solvent 2. 
Interleukin 1 (IL-1) Release. IL-1 release was determined by the 
method of Koide et al (164,165). using conditioned medium from 48 hr 
control macrophage and foam cell cultures. Serial dilutions of the culture 
supernatant were added to wells of a 96-well plate containing 2-3 x 10* D10 
G4.1 cells/well. D10 G4.1 is a T lymphocyte cell line which proliferates in 
response to IL-1. Proliferation was determined following a pulse of 0.5 JuCi 
3H-thymidine (Schwartz Mann division of Becton Dickinson, Orangeburg, NY) 
for 16 hr. Murine recombinant IL-1 (gift of Dr. P. Lomedico, Hoffman-
LaRoche) was used as a standard. At least 6 dilutions of each supernatant 
were assayed in duplicate and the number of IL-1 U/ml of the original 
supernatant was determined by linear regression analysis. 
Chapter 3 Effects of Reagent and Cell-generated H2O2 
on the Properties of L D L 
Introduction 
Many studies have suggested that endothelial cells, smooth muscle 
cells and circulating leukocytes can modify LDL, resulting in its subsequent 
enhanced uptake and degradation by mouse peritoneal macrophages via the 
scavenger receptor that recognizes chemically modified forms of LDL (59-
67). This biological modification of LDL leads to enormous cholesterol ester 
accumulation in macrophages (59,60), and it is believed to accelerate foam 
cell formation in vivo, contributing to the formation of the fatty streak 
precursor lesions of atherosclerosis. While exiting to the circulation, the 
lipid-laden foam cells may disrupt the endothelial ceils lining the artery, 
thereby exposing the underlying matrix to lipoproteins and platelets from 
the blood. This would mark the initiation of a major atherosclerotic plaque. 
The mechanisms postulated to underlie the cell-mediated modification 
of LDL include oxidation, lipolysis, and proteolysis (61-67). The biological 
modification of LDL has been reported by Steinbrecher et al to coincide with 
the acquisition of thiobarbituric acid (TBA) reactivity, representing oxidation 
of the lipid portion of LDL. In no instance has this alteration been clearly 
defined in molecular terms. For this reason, w e undertook a detailed study of 
the role of a major oxidizing secretory product of phagocytic cells, H2O2. H2O2 
is a relatively long lived, uncharged product of the reduction of molecular 
oxygen that can pass across biological membranes (166,167) and oxidize 
substrates at both intracellular and extracellular sites. W e have examined 
the susceptibility of LDL to oxidation by known concentrations of chemical 
oxidants, by endothelial cells, and by the diverse group of reactive oxygen 
intermediates produced by monocytes. In addition, w e have investigated the 
ability of monocytes and macrophages to respond to modified LDLs by 
releasing H2O2. The results suggest two conclusions: first, that LDL is 
relatively resistant to the generation of TBA-reactive moieties by the 
concentrations of reactive oxygen intermediates secreted by a widely-
studied rabbit aortic endothelial cell line or by human monocytes; and 
second, that biological modification of LDL can proceed in the absence of its 
detectable oxidation. 
Results 
Characterization of H2O2-oxidized LDL. The common assay of 
oxidation of LDL used by Steinbrecher et al (61), by us, and by many others 
is the TBA assay, which measures malondialdehyde-equivalent oxidation 
products of conjugated unsaturated fatty acids. A fluorescent pigment is 
formed by the combination of two TBA molecules with such a lipid product. 
In LDL, sources of this material are the phospholipids and triglycerides, a 
small proportion of the total lipid of the particle. The quantities of defined 
oxidants required to generate a given level of reactivity of LDL in the TBA 
assay have, to our knowledge, not been reported. Accordingly, w e tested the 
effects of various concentrations of H2O2 and the products of its metal-
catalyzed redox reactions, using the same serum-free culture medium 
employed by others for cell-dependent modification of LDL. Fig 3-1 
characterizes LDL that was reacted with reagent H2O2 and tested for 
oxidation of lipid in the TBA assay and for alteration of the apoprotein by 1 % 
agarose and 3-10% gradient SDS gel electrophoresis, as described in methods. 
Figure 3-1. Characterization of H202-oxidized LDL. EDTA-LDL and CDP-LDL 
at 100 Atg/ml in Ham's F-10 medium were treated with various 
concentrations of H2O2 for 3h at 37 °C a. Coomassie blue-stained 1% 
agarose gel in barbital buffer system, pH 8.6. 20 pg LDL per lane. 
H202 concentration: lane 1, 0; lane 2, 1x10"* M; lane 3, 3x10"* M; lane 
4, lxlO-3 M; lane 5, 3xl0"3 M; lane 6, lxlO"2 M; lane 7, 3xl0"2 M; lane 
8, lxlO"1 M. b. Oxidation measured by the TBA assay of EDTA-LDL (A A) 
3 and CDP-LDL (O- - - O). Data are the mean of 6 experiments ±. SEM. c. 
Silver-stained 3-10% gradient SDS-PAGE of 20 /*g LDL samples treated 
with H202, concentrations in each lane as in fig la. 
Figure 3-1 
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Within each experiment, a single donor's plasma was used to compare EDTA-
LDL and CDP-LDL. As shown in Fig 3-IB, only concentrations of H2O2 above 3 
x 10-* M induced TBA reactivity in EDTA-LDL, with 3 x 10"3 M H2O2 required 
for maximal reactivity. The dose required to reach half-maximal reactivity 
(ED50) of H2O2 was 1.7 x 10-3 M for EDTA-LDL. However, CDP-LDL was 4-fold 
more sensitive to oxidation by H2O2. showing TBA reactivity above 
background at 3 x 1(H M, a maximum value at 1 x 1Q-3 M, and ED50 at 4.5 x 
10"4 M. The decline of malondialdehyde values at supramaximal 
concentrations of H2O2 probably reflects lipid oxidation to other products not 
measured by this assay. 
The agarose gel (Fig. 3-1 A) shows the increased negative charge of 
EDTA-LDL reflected by its increased migration after oxidation by increasing 
concentrations of H2O2. The plot of Rf values versus the logarithm of 
concentrations was linear above 1 m M H2O2. At 0.3 M H2O2, the highest 
concentration tested, the Rf value was 0.48. By extrapolation, 3 M H2O2 
would be required to generate the Rf value of 0.51 seen for acetoacetylated 
LDL. 
Similarly, the SDS gel (Fig. 3-1C) shows the 420 kd band of the 
apolipoprotein B of EDTA-LDL gradually diminished in lanes 4-8 with 
increasing concentrations of H2O2. Above 1 mM, the protein was extensively 
degraded to lower M r peptides. 
Cell-derived reactive oxygen intermediates other than H2O2 may be 
involved in oxidizing LDL. Consequently, w e next tested the sensitivity of 
LDL to oxidation by H2O2 in combination with cuprous or ferrous ions 
(Fenton's reagent, a source of 02" and OH- ;168), and with lactoperoxidase and 
Nal (to generate hypohalous ions; Table 3-1). At 0.3 m M H2O2, TBA 
reactivity was 1.33-fold above control when lactoperoxidase/Nal was added, 
Table 3-1. Effect of Additions to Reagent B 20 2 on Oxidation of LDL 
(nmoles MDA/ 100 pg LDL) 
H-Q2 no add. LPO/Nal FeSO^ CuSO^ SOD/Cu^ Mann/Cu^ 
0.3mM 0.6 ±.13 0.8 ±,16 0.6 ±.29 1.4 ±.14 0.4 ±^08 1.0 ±.22 
p<0.05 NS p<0.01 p<0.02 HS 
3.On*! 2.1 ±.26 2.5 ±.34 2.1 ±.29 2.S±.34 2.6±.44 2.5±.48 
p<0.01 HS p<0.C5 NS NS 
i£ 8 5 4 8 4 4 
CDP-LDL was incubated at 37 "C in Ham's F-10 medium for 3h as described in Materials and Methods. 
Data are means ± SEM for the number of experiments indicated. Significance of difference between each 
addition and no addition was assessed with the two-tailed t test. NS - p>0.05. CuSO^ was 10 pM, FeSO^ 
was 50 iM, SOD was 30 U/ml, mannitol was 50 pM, LPO was 100 mU/ml, Nal was 100 «M. With no %2°2-
CDP-LDL had 0.4 ± .05 nmol MDA/100 Mg LDL. n"*t *»d CDP-LDL with Cu** had 0.8 ± 0.1, n-5. Medium 
alone and with all additions tested with H202 showed 0 MDA. 
and 2.33-fold above control in the presence of Cu2+. Addition of superoxide 
dismutase to the LDL incubations containing Cu2+ and H2O2 abolished the 
enhancement in TBA reactivity, suggesting that the effect of Cu2+ may be 
due to generation of O2' or a product of O2" and H2O2, such as 0H-. Both Cu2+ 
and lactoperoxidase/Nal were able to increase slightly the effect of 3 m M 
H2O2. The maximum observed TBA value in our experiments was 4 nmoi 
MDA/lOOygLDL. 
Coincubation of LDLs with Endothelial Cell Monolayers. W e 
next examined the effect of the coculture of LDL with endothelial cells (EC-
LDL), reproducing closely the conditions employed by Steinbrecher et al. 
(61). As shown earlier for H202-oxidized LDL, w e noted significant 
differences between EDTA-LDL and CDP-LDL (Fig. 3-2 A and B). Endothelial 
cells appeared to retard the formation of TBA reactivity for EDTA-LDL, since 
EDTA-LDL incubated in the cell-free flasks had twice the TBA value of that 
incubated in the presence of cells. This difference was even more 
pronounced when 10 juM Cu2+ was present, in which case cell-free incubated 
EDTA-LDL was about three times as TBA-reactive as the sample incubated 
with endothelial cells. However, for CDP-LDL, the TBA reactivity was very 
similar for LDLs incubated in the absence or presence of endothelial cell 
monolayers, and the enhancement in oxidation due to Cu2* was also less, 
probably because the original level was high. Thus, w e were unable to 
demonstrate endothelial cell-dependent oxidation of LDL by means of TBA 
reactivity. The linear relationship between TBA oxidation and Rf values on 
agarose gels was maintained in these experiments (data not shown). 
EC LDL Degradation by Murine Macrophages. In confirmation of 
the biological modfication described by Steinbrecher et al, we measured 
increased macrophage degradation of EC-LDL. Degradation is an indication of 



































Figure 3-2. Endothelial Cell Modification of LDL. TBA assay of samples of 
100 \i% LDL/ml after 24 h incubations in Ham's F-10 medium in the 
presence (solid bars) or absence (hatched bars) of cells as indicated 
(+ EC). For EDTA-LDL, n-22 independent experiments without copper, n-11 
with copper. For CDP-LDL, n-8 without copper, n-5 with copper. Data are 
means ± SEM. 
Table 3-2 
Mouse Macrophage Degradation of LDL 
Degradation 
Preincubated* With ng LDL/me/Sh 
Endothelial Cells 11.43* 1.14 
Medium alone 3.80+ 1.32a 
Not preincubated 2.45 i 0.14a 
*125l-LDL (100 jug/ml) was incubated for 24 h in 
serum-free Hams F-10 medium before incubation 
with mouse macrophages. Data are the means ± SD for 
3 experiments, a - P< 0.02 for each sample compared 
to preincubated with EC. 
Table 3-3 
Mouse Macrophage Degradation of LDL 
Preincubated* With 
Endothelial Cells (EC) 
EC + SOD + Catalase 




U B LDL/me/Sh 
4.48 + 0.23 
4.05 + 0.80* 
3.98 ± 0.30b 
1.46 + 0.16 
1.39 + 0.17 
*125l-LDL (100 jug/ml) was incubated for 24 h in 
serum-free Hams F-10 medium before incubation 
with mouse macrophages. Data are the means + SD 
for 3 experiments, a - not significant, b - P< 0.05 for 
each sample compared to preincubated with EC. 
cell binding and ingestion of the LDL. Three forms of LDL were compared for 
the rate of degradation by cultures of resident mouse peritoneal macrophage 
monolayers: 125l-labeled LDL incubated with endothelial cells (l25l-labeled 
EC-LDL), 125l-labeled LDL incubated without endothelial cells, and not pre-
incubated 125l-labeled LDL. In agreement with previous reports (59-61,63-
65,69), 125l-labeled EC-LDL was degraded 3-5 times more rapidly by mouse 
macrophages than either the 125l-labeled LDL incubated without endothelial 
cells, or the not pre-incubated 125l-labeied LDL (Table 3-2). A separate set of 
experiments shown in Table 3-3 has different baseline values, but shows 
clearly that the addition of the anti-oxidants superoxide dismutase (SOD; 80 
ug/ml), catalase (1000 U/ml). butylated hydroxytoluene (BHT; 20 uM). or 
vitamin E (100 juM) to these preincubations only slightly reduced the rate of 
degradation of LDL by mouse macrophages, while completely eliminating 
TBA reactivity (data not shown). Thus, all samples of LDL preincubated with 
endothelial cells showed higher rates of degradation by mouse macrophages 
than the LDLs preincubated without endothelial cells, with or without anti-
oxidants. 
Determination of Endothelial Cell H2O2 and O2" Release. To 
evaluate the oxidizing potential of these endothelial cells, w e tested their 
ability to release H2O2 and O2". Table 3-4 shows an apparent oxidation of a 
very small amount of the scopoletin indicator, about half of which is shown 
to be H2O2 independent by the controls omitting horseradish peroxidase and 
adding catalase. The addition of superoxide dismutase did not result in any 
increase in the 5 nmol of H202/mg/2 hr detected, suggesting that these 
endothelial cells released extremely little O2". 
Monocyte Oxidation of LDL. As confirmed above, endothelial cells 
are not reported to secrete abundant reactive oxygen intermediates (169). In 
Table 3-4. Release of H2O2 by Endothelial Cells 
Condition -PMA +PMA 
nmoles H2O2/ mg protein/2h 
complete system 10.7 ±4.9 12.0 +.5.4 
plus SOD (30 U/ml) 9.1 +5.3 12.9+5.4 
plus catalase (300 U/ml) 4.1 +2.2 3.4+_2.0 
minus HPO (background) 4.8 +2.5 9.4 +_ 4.2 
Rabbit EC were trypsinized and plated in a 96-well plate for assay 
2-3 days later. Phorbol myristate acetate (PMA) at 100 ng/ml was used 
as a potential secretagogue. Three separate experiments were done 
over a range of cell protein values (2-20 **g/well.) In each 
experiment n-9 for control, n-5 for experimental. The data are means 
+_ standard errors of the mean. Complete system was Krebs-Ringer 
phosphate buffer with 5.5 mM glucose, 1 mM NaN3, 1 purpurogallin 
unit/ml horseradish peroxidase (HPO), 25 iM scopoletin. 
Figure 3-3. Mononuclear (MNL) Cell Oxidation of LDL. a. Time course for 8 
x 10° MNL plated/16 mm well. Plates were rinsed after 2h and LDL was 
added at 100 /ig/ml in Ham's F-10 medium. Data are the means of four 
experiments ± SEM. The three samples tested are of LDL without cells 
(• Q) ©r cells in the absence ( A—— A) and presence (• • ) of 
PMA. b. Dose curve of MNL plated as above with data taken at time — 3 
h. n«3. Means + SEM.(# ft) with PMA; (A A) no PMA. 











1 1 1 1 
6 8 10 12 
Time in hours 
14 16 18 
4 6 8 





contrast, human monocytes are potent sources of O2", H2O2, OH, and a 
myeloperoxidase halogenation system (150,170). Thus, even though 
monocytes do not secrete enough H2O2 to attain the concentrations producing 
TBA reactivity in Fig. 3-1, their production of additional, more potent 
oxidants might make them effective producers of TBA reactivity in LDL. 
Accordingly, freshly isolated human mononuclear leukocytes were plated at 
8 x 106 cells perl6-mm well, rinsed after 2 hr of incubation to remove 
nonadherent cells, and CDP-LDL at 100 jug/ml was added, using the same 
medium as in the endothelial ceil experiments, in the presence and absence 
of 100 ng/ml P M A to trigger the respiratory burst. In assays lasting up to 17 
hours, the TBA assay did not reveal any cell-dependent oxidation of LDL (Fig. 
3-3A). The TBA reactivity that is shown is approximately equal for the cell-
free samples and the samples in the presence of monocytes with or without 
PMA. Increasing the number of cells did not increase the cell-independent 
TBA reactivity seen after 3 hours (Fig. 3-3B). 
Monocyte/Macrophage H2O2 Release with LDLs as Triggers. 
Ligands of the scavenger receptor have been shown to trigger macrophage 
secretory functions (142). A final query concerned the ability of native and 
modified LDLs to trigger the release of reactive oxygen inter mediates~H202, 
02", OH«, and hypohalous ions—by monocytes and macrophages via this 
mechanism (Table 3-5). Monocytes, cultured macrophages, and macrophages 
treated with human recombinant IFlfy were exposed to the lipoproteins, and 
their respiratory burst response was compared with that elicited by PMA, 
using H2O2 as a marker. The level of H2O2 release by fresh monocytes in the 
presence of modified LDLs was only slightly changed in comparison to the 
model secretagogue, PMA. The PMA-induced H2O2 releasing capacity 
declined with time in culture, but the cells could be kept near the original 
Table 3—5. LDLs as Triggers for H^O, Release from Human Monocytes and Macrophages 
Condition Monocytes Macrophages 
rIFN-7 + 
PMA + + - + 
control 26+9 520 +39 18 +_8 62+28 54 +.29 432 +_214 
CDP-LDL 58 +.26 686 +106 8 + A 101 + 19 50 +14 301 +_76 
EDTA-LDL 54 _+ 13 623 +_ 94 57 +_ 14 124 ± 15 56 +_ 17 343 +_ 87 
AcAc-LDL 68 + 10 699 + 74 54 +. 16 143 ±15 63 ± 15 322 +_ 61 
mock AcAc-LDL 75 dL 7 648 ± 94 26 ± 5 117 +_ 20 67 ± 12 269 +_ 60 
LDLs were used at 100 Mg/ml in assay buffer. H202 is expressed as nmoles/mg cell protein/h for 
monocytes tested on day of harvest and per 3h for macrophages tested after 7 days of culture. Values 
are means of 4-6 experiments ± SEM. rIFN-7 was 100 U/ml. PMA (phorbol myristate acetate) was at 100 
ng/ml. 
level by the additon of recombinant IFfy. Only small changes in release were 
observed with native or modified LDLs at 100 jug/ml. although Oil Red 0 
staining of replicate coverslips showed lipid accumulation. 
Discussion 
Incubation of EDTA-LDL with endothelial cells or smooth muscle cells 
in the absence of serum leads to modification resulting in more rapid 
degradation of the LDL when subsequently added to cultures of mouse 
macrophages (59-61,63-65.69). Such LDLs were markedly positive in the 
TBA assay, which has led to the widely embraced interpretation that a 
primary effect of endothelial cells and smooth muscle cells upon LDL is its 
oiidation. Experiments with inhibitors suggested that cell-derived H2O2 and 
O2" were critical to generate the modifications resulting in enhanced 
degradation by macrophages (61,63-65). 
Human umbilical cord endothelial cells have been reported to secrete 
65 nmol of H2O2 per mg of protein per 90 min (169) and monkey and human 
aortic smooth muscle cells were reported to secrete 0.3-3 nmol of O2" per mg 
of protein per min (65). However, using the rabbit aortic endothelial cell line 
(59), with corrections for nonspecific loss of the fluorescent indicator, w e 
detected only 6 nmol of H2O2 per mg of protein per 2 hr. Our measured value 
of endothelial cell-derived H2O2 (less than 0.3% of the H2O2 produced by 
triggered fresh human monocytes, 800-1000 nmol per mg per hr; 150) can 
be extrapolated tol juM per hr per 25-cm2 flask. This value was not 
increased by the addition of 90 jum L-cystine (data not shown; 171). If 
endothelial cell H2O2 production is linear over 24 hr and if endothelial cell-
derived H2O2 accumulates without any other reactions, this would represent 
three orders of magnitude less H2O2 than was required to yield 
malondialdehyde values of 3 nmol per 100 ug of LDL seen for EDTA-LDL in 
the same medium (Fig. 3-1). The amounts of reactive oxygen intermediates 
required to generate TBA-positive LDL have not previously been quantified 
or compared to cellular rates of secretion. 
W e have confirmed that rabbit endothelial cells modify LDL for 
enhanced uptake by macrophages but have been unable to demonstrate that 
this is associated with induction of TBA reactivity. Indeed, the quantities of 
oxidants required to yield TBA-reactive LDL ( m M range) are orders of 
magnitude higher than those detectable under similar conditions for the 
same endothelial cells, or even for monocytes, potent sources of all the 
reactive oxygen intermediates known to be secreted by cells. A calculated 
value of only 0.1 m M H2O2/2 hr was seen in our assay with monocytes, Fig. 
3-3. These data suggest that the increase in rate of degradation of EC-LDL by 
macrophages was not due to oxidation by endothelial cells as manifest by 
TBA reactivity, but rather to some other influence of the endothelial cell 
monolayer. 
The EDTA in the LDL used by Steinbrecher et al. (61) could be 
expected to suppress metal ion-dependent oxidation (172,173), and w e 
confirmed that EDTA-LDL (0.26 m M EDTA) was 4-fold more resistant to 
induction of TBA reactivity than was LDL prepared without EDTA (CDP-LDL). 
Nonetheless, even CDP-LDL was highly resistant to generation of TBA 
reactivity by H2O2 and metal ions. Of course, biologically important oxidation 
not measured by the TBA assay may have occurred. 
W e cannot explain the marked differences in generation of TBA 
reactivity among apparently similar studies (61,62,174), but suspect that an 
ancillary factor may be involved, such as phospholipase or proteases 
contaminating some preparations of LDL. Degradation of apolipoprotein B 
accompanying auto-oxidation of LDL has been observed by Schuh et al. 
(172). W e observed the presence of multiple low M r bands on SDS gels of EC-
LDL samples but not of LDL incubated without endothelial cells (data not 
shown). This can be seen clearly also in ref. 64. W e suggest that the 
biological modification of LDL may include proteolytic degradation. 
Although neither the endothelial cells nor monocytes efficiently 
oxidized LDL in a fluid environment, oxidation may take place in the artery 
wall. The presence of both matrix-bound LDL and large numbers of 
monocytes in the confines of a subendothelial fatty streak (from which 
serum, a suppressant of cell-dependent modification of LDL, is excluded) 
would allow more intimate interactions of the substrate and effector cells. 
Additional enhancement might occur if T-cell derived IFN$ were also present 
(175). LDL re-isolated from vessels has altered lipid composition and 
electrophoretic mobility, similar to in vitro modified LDL (115-119). 
Further, w e could not demonstrate triggering of H2O2 release from 
human monoctyes or macrophages, with or without IFNy, by a variety of 
modified LDLs. W e used both monocytes and mature macrophages, which 
have the scavenger receptor that has been shown to regulate macrophage 
secretory function (142). 
Thus, the present studies lend no support to the notion that oxidation 
of LDL lipid to maiondialdehyde-like moieties reactive with TBA is a 
prominent reaction caused by endothelial cells or monocytes, or that 
modified LDLs in turn trigger reactive oxygen intermediate release from 
inflammatory cells. The molecular basis of the modification of LDL by 
endothelial cells that leads to its enhanced uptake by macrophages remains 
to be defined. 
Chapter 4 The Endocytic and Secretory Repertoire of the 
Lipid-loaded Macrophage: A n in vitro Model for Foam Cells 
Introduction 
As described in chapter 1, a critical feature of the atherosclerotic 
plaque has not been examined: that is, what are the functional properties of 
a macrophage-foam cell? After the extensive iipid-loading, and contact with 
numerous cytokines and endocytic stimuli, these cells may no longer be 
capable of macrophage functions. W e have undertaken the following studies 
to evaluate the endocytic and secretory capacities of the lipid-loaded 
macrophage. From the large number of activities associated with the 
macrophage, w e first evaluated the phagocytic capacity of the cells by 
measuring Fc-mediated endocytosis of immunoglobulin-coated erythrocytes. 
Next w e surveyed cellular and secreted proteins by metabolic labeling. This 
was followed by the measurement of selected secretory products that would 
have a large impact in the arterial environment, including apolipoprotein E, 
neutral proteases, H2O2, and the arachidonic acid metabolites. Finally, w e 
began studies, preliminary results of which are reported below, on 
macrophage and lipid-laden cell response to IFNy, and release of 
interleukin-1. 
Cholesterol Accumulation 
Normal mouse macrophages maintain a constant ratio of cholesterol to 
protein and have no cholesterol esters. 95% of the cholesterol is membrane-
associated, mainly in the plasma and the lysosomal membranes (176). 
Macrophages exchange 30% of their cholesterol with the medium per hour 
when cultured in 20% calf serum. A kinetic analysis of cholesterol exchange 
shows that macrophages have one fast-exchanging compartment 
representing 60-70% of the cellular cholesterol, which is the plasma 
membrane. The slower exchanging compartment (the remaining 30-40% of 
cellular cholesterol) is intracellular, probably largely made up of the 
lysosomal membranes (177). Excretion of cholesterol from the macrophage 
requires a suitable acceptor in the medium, such as serum, high density 
lipoprotein, or intact erythrocytes, and the rate of exchange is proportional 
to the concentration of acceptors in the medium (176,179-183). Cholesterol 
efflux and exchange occur via a trypsin-sensitive membrane component 
which requires protein synthesis to restore activity after proteolytic 
degradation (177,182). 
W h e n resident mouse peritoneal macrophages in culture are loaded 
with Ac-LDL, macrophages store excess cholesterol in an esterified form. 
After endocytosis, the LDL-derived cholesterol esters are hydroiyzed in the 
lysosomes by a lysosomal cholesterol esterase that has optimal activity at pH 
4.0 (178-180). The free cholesterol thus generated can then be exchanged to 
a suitable acceptor, as described above, or re-esterified in the cytoplasm. The 
cholesterol esters accumulate in the cytoplasm and undergo a continuous 
cycle of hydrolysis to free cholesterol followed by re-esterification by ACAT. 
This process occurs with a half-life of 24 hours, requires ATP, and has been 
called the "cholesteryl ester cycle," a futile cycle (180). Two cytoplasmic 
cholesterol esterases that hydrolyze the cholesterol esters for efflux have 
been reported, one from the arterial wall and the other from macrophages. 
They are both regulated by cAMP-dependent protein kinase, and have 
neutral pH optima (184,185). 
Morphology of Lipid-laden cells 
Figure 4-1 shows pairs of photographs of day 2 macrophage cultures 
at 40x with the same field of cells seen under phase microscopy and in 
bright field. Mouse peritoneal macrophages were used in the foam cell 
experiments as a convenient source of mature tissue macrophages. The 
control cells (A) show a population of adherent cells— some cells are flat 
and pancake-like, while others are rounded, or elongated, reflecting the 
normal population of macrophages from the peritoneal cavity of an 
unstimulated mouse. After fixation and Oil Red 0 staining (156), seen in 
bright field, control cells show almost no red color. A few cells at the lower 
right show some faint staining. These are the larger, pancake cells. All three 
lipid-loading regimens result in accumulation of Oil Red 0 stainable material. 
The cells in B were loaded with 200 ug/ml Ac-LDL. These are called 
Ac-LDL cells, and they represent cells lipid-loaded through the scavenger 
receptor. They act as a model for EC-LDL. The phase photograph shows a 
large number of inclusions in the cells which are shown in bright field to 
stain strongly with Oil Red 0. reflecting lipid content. 
The pair of pictures labeled C represent cells fed M-10 with 10 ug/ml 
dextran sulf ate-LDL (DS-LDL) complexes. The atherosclerotic plaque is highly 
enriched in sulfated glycosaminoglycans (76,77), which avidly bind LDL. DS-
LDL complexes serve as a model for the extracellular matrix-bound LDL in 
the artery wall. Oil Red 0 stains these cells the most dramatically. 
Serum components such as HDL are required for the release of 
cholesterol from the macrophages. The cells in D are loaded with M E M with a 
reduced serum concentration to reduce the amount of HDL and therefore 
Figure 4-1. 40X photographs of Oil Red 0 stained mouse macrophages. 
Ceils were cultured 2 days and then fixed in formalin and stained with Oil 
Red 0. Panel A. control ceils; Panel B, Ac-LDL cells; Panel C. DS-LDL cells; 
Panel D. LS/01 ceils. 
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Table 4-1. Cholesterol content of foam cells 
Culture condition Cholesterol.^g/mg cell protein * 
M-10 83.9 ± 7.7 
Ac-LDL 113.3 ± 8.9 
DS-LDL 212.3+17.1 
LSZQ1 138,7 ±11,4 
* Mouse macrophages were cultured as described for 2 days and then lipids 
were extracted by the method of Bligh and Dyer, and cholesterol was 
determined in the fluorescent assay of Gamble et al (see methods). Data are 
means t SEM. P<.001 for all lipid-fed samples compared to control. n= 21-39 
separate determinations. 
reduce the amount of cholesterol that could be exchanged. These cells had 
Ac-LDL in the same amount as above, and oleic acid to enhance macrophage 
cholesterol esterification. BSA in one-fourth the concentration of serum was 
added as a carrier of the oleic acid. These cells are called low serum/oleic 
cells, or LS/01. 
Cholesterol levels were determined using p-hydroxyphenylacetic acid, 
which detects the H2O2 enzymatically generated from cholesterol by the 
action of cholesterol oxidase and whose oxidation product is fluorescent 
(155). In each experiment the lipid-fed cells showed significant increases in 
total cholesterol (free and esterified) as compared to control M-10 fed cells 
(Table 4-1). Ac-LDL fed cells and LS/01 cells had between 1.4-1.7 fold more 
cholesterol loading than control M-10 cells. DS-LDL fed cells consistently 
showed the largest increase in cholesterol levels, 2.5 fold over control. 
W e examined the kinetics of lipid loading of resident peritoneal 
macrophages in vitro for up to 12 days. As shown in Figure 4-2, the 
macrophages fed DS-LDL quickly accumulated lipid so that after 1 day in 
culture they were 1.8-fold above control cells in cholesterol content. The 
amount of cholesterol per cell was maintained at about 270 jug/rag cell 
protein after day 3, to a level that was 4.5-foid above control cells. The 
initially high control cell cholesterol level dropped over 3 days in culture but 
was maintained thereafter at about 60 jug/mg protein. Cells that were loaded 
with DS-LDL for 2 days and then changed to M-10 medium for the 
remainder of the 12 days showed a fast initial drop in cholesterol level from 
260 ug/mg to 180 jug/mg by day 3. However, about half of the cholesterol 
loaded was not lost during the 12 days. This may be due to the DS-LDL 
complexes. DS itself is poorly digested by macrophages (140) and may trap 
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Figure 4-2. Mouse macrophages were cultured up to 12 days and 
assayed for cholesterol at the times shown. Solid line, control cells. Bold Line. 
DS-LDL cells. Dotted line, cells fed DS-LDL for 2 days, and then control 
medium for 10 days. Data are averages t SD for n-4 samples. 
some cholesterol in the secondary lysosomes where it would not be available 
to be eichanged. 
These increases in total cell cholesterol can also be measured by 
quantitating the Oil Red 0 staining in the cells (156). After 2 days of culture, 
coverslips were fixed and stained, and then extracted in dioxane. The optical 
density at 530 n m (OD530) was measured against a dioxane blank. The fold 
over control of OD530 was nearly the same as that measured by total 
cholesterol determination. Some variability was observed between 
experiments. However, within any experiment the increase over control was 
very consistent (Table 4-2). 
The lipids in these lipid-laden cells were also examined by thin layer 
chromatography (TLC), as shown in Figure 4-3. One dimensional TLC was 
performed using the 2 solvent system of Falcone et al (157). Total cellular 
lipids were extracted in situ with hexane, dried under N2. and spotted onto 
silica plates. After separation, the plates were stained with rhodamine and 
photographed under ultraviolet light. Lane A in both experiments shows the 
separation pattern of lipids from M-10 fed control cells, including free 
cholesterol and triglycerides. Almost no cholesterol ester is seen in normal 
macrophages. In contrast, all three lipid-loaded macrophage populations 
show an enormous accumulation of cholesterol ester. This is particularly 
prominent in lanes C and D. the DS-LDL fed and LS/01 cells. However, Ac-LDL 
cells also show large amounts of cholesterol ester. The lipid-loaded cells also 
show more free cholesterol and triglycerides than control cells. The TLC 
plates graphically illustrate the increases in lipid seen in the Oil Red 0 
stained ceils and quantified by Oil Red 0 extraction and the cholesterol assay. 
Phagocytosis 
Figure 4-3 
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Figure 4-3- Mouse macrophages were cultured for 2 days and then 
lipids were extracted and chromatographed according to the method of 
Falcone et al (157). Plates were stained with rhodamine and photographed 
under UV light. Lane A, control cells; Lane B, Ac-LDL fed cells.;Lane C, DS-LDL 
fed cells; Lane D, LS/01 fed cells. 
Table 4-2. Extraction of Oil Red 0 from foam cells 
Optical Density. 530 nm, fold over control * 
Culture condition expt. 1 expt. 2 
M-10 1.0 1.0 
Ac-LDL 1.2 2.4 
DS-LDL 2.6 2.4 
LS/Q1 22 L6 
* Mouse macrophages were cultured as described, fixed and stained on day 
2, and extracted in dioxane. OD of control macrophages was 0.048, n-2 per 
experiment, range < 10%. 
Phagocytosis is a hallmark of macrophage function. Foam cells in the 
artery wall would be surrounded with LDL and LDL-GAG complexes, as well 
as tissue debris, and it is important to know if they can actively scavenge 
after lipid-loading. In addition. Fc-mediated uptake serves as a natural 
trigger for the three secretory functions that will be examined next. W e 
measured the ability of lipid-laden cells to phagocytose sheep erythrocytes 
coated with immunoglobulin G (EIgG) for 45 minutes at 37 °C. Both 
attachment and phagocytosis of EIgG were determined. As shown in Table 
4-3, nearly all the cells (94-97%) were able to bind EIgG. and approximately 
equal numbers of erythrocytes were bound per cell regardless of the lipid 
loading regimen. The number of cells with EIgG attached and the number per 
cell agrees well with published values (186). Similarly, a large percentage of 
the population was able to ingest EIgG and the number of erythrocytes per 
cell was almost equal in each condition. W e can thus conclude that lipid-
loading does not change Fc mediated endocytosis by mouse macrophages. 
35s-Methionine Protein Profile 
Introduction. Macrophages secrete a large number of proteins with 
varied functions and regulate their release of these products in response to 
environmental signals (187). Some secreted products like lysozyme are 
constitutively released regardless of the state of activation. Lysozyme only 
acts on the ty-1,4 N-acetyl glucosamine linkages of bacterial cell walls and its 
constitutive production is not known to be harmful (188). In contrast, the 
group of neutral proteases—plasminogen activator, elastase, and 
collagenase—can damage cellular proteins, particularly proteins of the 
Table 4-3. Binding and phagocytosis of EI2G bv foam cells* 
Attachment Index Phagocytosis Index 
Culture condition % cells w/E #E per cell % cells w/E #E per cell 
M-10 94 ±0 8.1 ±1.0 91 ±4.5 4.6 ± 0.3 
Ac-LDL 96 ±2.8 7.8 ±1.3 88 ± 6.2 4.9 ± 0.9 
DS-LDL 97 ±3.0 5.8 ± 0.4 96 ±1.5 5.1 ± 1.7 
LS/01 96 ±2.4 7.7 ±2.0 93 ±2.0 ^±0.1 
* Mouse macrophages were cultured as described for 2 days. Cells were 
washed twice and incubated with EIgG (see methods) for 45 minutes. A brief 
wash with distilled water removed uningested E, to provide phagocytosis 
data. Attachment index and phagocytosis were determined by counting 
under water immersion # E/100 cells, using a Nikon 40x lens. Data are 
means ± SD, n=3 for all except DS-LDL, where n=2. 
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extracellular matrix (189). Secretion of these enzymes is very low in resident 
cells, but increased in inflammatory macrophages. Other proteins like the 
lysosomal acid hydrolases are secreted only by activated cells or in vitro in 
response to stimuli like immune complexes, P M A or zymosan (190). 
W e next observed a large number of the cellular and secretory 
proteins of lipid-laden macrophages by metabolic labeling with 35s-
methionine, shown in Figures 4-4 through 4-7. Since they illustrate such a 
broad number of activities, the profiles can be a revealing indicator of 
cellular condition. 
Results. Analysis of 35s-methionine-labelled cellular proteins from 
lipid-laden cells is shown in Figure 4-4. Lane A shows the control band 
pattern. Although w e cannot identify very many of the numerous bands, it 
appears that many of the intracellular proteins are still produced after lipid 
loading. 
SDS-PAGE of secreted proteins, however, shows several differences. In 
all four conditions shown in Figure 4-5, secreted proteins made up 18-23% of 
the total radioactivity. In the autoradiograms shown, LS/01 cells' 
incorporation of labeled methionine was only 45% of control, and so an 
additional, darker exposure of that lane is shown at the far left of the figure 
to facilitate comparisons. DS-LDL fed cells incorporated only 71 % of control. 
Since BSA- and DS-fed macrophages have been shown to be more 
pinocytically active than control cells (191), w e may assume that these cells 
were exposed to at least as much radiolabel as the control and Ac-LDL fed 
ceils, and that the lower incorporation of label reflects a decrease in protein 
synthesis. The M-10 control cells, at the far right of the figure, show the 
typical pattern of secretory proteins for resident mouse peritoneal 
macrophages in adherent culture. There is a prominent band at 220,000 Mr, 
Figure 4-4 
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Figure 4-4. Mouse macrophages were cultured for 2 days and then 
labeled with 35s-methionine for 4 hours. Cell monolayers were lysed in SDS 
sample buffer, loaded onto a 7-18% gradient SDS gel, electrophoresed and 
processed for autoradiography. Lane A, control; Lane B, Ac-LDL; Lane C, DS-
LDL; Lane D, LS/01. 
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Figure 4-5- Mouse macrophages were cultured for 2 days and then 
labeled with 35s-methionine for 4 hours. Secreted proteins were precipitated 
with trichloroacetic acid and resuspended in SDS sample buffer before being 
loaded onto a 7-18% gradient SDS gel, electrophoresed and processed for 
autoradiography. Samples are as marked. 
which is probably fibronectin (192). This band is present in all the lanes. 
Similarly, lysozyme, at 14 Kd, is constitutively expressed (193). 
A band at 90 Kd is increased in the DS-LDL fed cells. This may be 
complement factor B, which when activated can cleave and activate 
plasminogen (194,195). A prominent band at 68 Kd (p68) is increased in DS-
LDL fed cells and LS/01 fed cells. This unidentified protein has been reported 
by Takemura and Werb to be elevated after DS treatment of resident cells 
(196). This is also true for a more dispersed band at 51-55 Kd. Both DS-LDL 
fed and LS/01 cells showed increases in p68 as compared to control. 
Endocytic signals have been shown to affect secreted proteins enormously, 
and this phenotype may be a result of undigested endocytosed material in 
secondary lysosomes. The effect of DS-LDL loading on p68 production can be 
seen more clearly in Figure 4-6. Here, resident ceils were fed complexes of 
DS-LDL prepared with reduced quantities of DS and equal amounts of LDL. 
The ratio represents the proportion of DS to LDL used in the preparation of 
the DS-LDL complex. Lane A is the pattern of proteins secreted from cells 
loaded with DS-LDL complexes at 0.01:1, DS/LDL; the ratios for Lane B and 
Lane C are 0.1:1 and 1:1 respectively. The decreasing doses of DS-LDL reduce 
the cells secretion of the 68 kd protein. 
One of the most obvious changes in this profile is the protein at 33 Kd. 
This is apolipoprotein E (apo E), shown to be increased in resident cells that 
have been fed Ac-LDL (196,197). The secretion of apo E is highly regulated 
and can give information regarding the condition of the macrophage. It will 
be considered in detail below. 
Apolipoprotein E (apo E) 
Figure 4-6 
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Figure 4-6. Mouse macrophages were cultured for 2 days and then 
labeled with 35S-methionine for 4 hours. Secreted proteins were precipitated 
with trichloroacetic acid, resuspended in SDS sample buffer, loaded onto a 7-
18% gradient SDS gel, electrophoresed and processed for autoradiography. 
Lane A, cells fed DS-LDL complexes prepared with a 0.01:1 ratio of DS/LDL. 
Lane B, cells fed DS-LDL complexes prepared with a 0.1:1 ratio of DS/LDL. 
Lane C, cells fed DS-LDL complexes prepared with a 1:1 ratio of DS/LDL. 
Introduction. Apo E is a plasma glycoprotein that is a constituent of 
LDL, VLDL, and chylomicrons. It alone can account for the binding of VLDL to 
its receptor and the rate of degradation of VLDL (198-202). The 
conformation of apo E is influenced by its constitutive lipids. The purified 
protein tends to self-aggregate; it forms homo- and heterodimers by 
disulfide bridges (203). 
Apo E is secreted by mouse and human macrophages. Its secretion is 
developmentally regulated; bone marrow-derived macrophages secrete apo 
E after 9 days in culture with colony stimulating factor 1 (204). Apo E 
secretion from macrophages is monensin sensitive, suggesting that it is 
secreted through the Golgi apparatus. It has been identified near the Golgi by 
immunofluorescence (205, 206). Apo E is released from the macrophage with 
phospholipids, in the form of bilayer discs resembling nascent HDL. It 
appears as 33,000-35.000 M r due to sialic acid additions at the time of 
synthesis that are reduced by time in circulation (207). The secretion of Apo 
E is reported to be transcriptionally controlled (208). 
Apo E discs have been shown to be recognized by the high affinity LDL 
receptor on fibroblasts (207). By itself, apo E secretion does not relieve the 
cell of excess cholesterol. As stated above, cholesterol is only excreted to 
specific cholesterol acceptors in the medium, like HDL or albumin. Once in 
the medium, however, apo E discs may expand and take in liberated 
cholesterol. Thus, apo E is seen as a part of the "reverse cholesterol 
transport" route to the liver for excess cholesterol from lipid-loaded 
macrophages (205). In type III hyperlipoproteinemia or familial 
dysbetalipoproteinemia, apo E has a defective interaction with its receptor 
because of point mutations in the apolipoprotein (203). W h e n the E2 
phenotype (one of three isoforms that exists in humans) is homozygously 
expressed, patients have elevated VLDL levels leading to pathology (209). 
Apo E secretion is affected by endocytosis, presenting a complex 
picture of regulation depending on the substance ingested, on the prior state 
of activation of the cell, and on lysosomal storage. Most endocytic stimuli 
decrease apo E secretion; fucoidin and LPS do not increase apo E (196). W h e n 
mouse macrophages are cholesterol-loaded, apo E secretion increases, and it 
can be up to 12% of the protein secreted by the cell. However, Takemura and 
Werb have shown that this is not strictly due to the cholesterol content, since 
EIgG feeding, which increases cholesterol, does not increase apo E secretion. 
It was of particular interest to us to measure the level of secreted apo E in 
cells that had been exposed to DS-LDL complexes. These cells have the highly 
elevated cholesterol content expected to increase apo E, and the presence of 
lysosomal DS shown to decrease apo E secretion (196). 
A fraction of LDL, LDL-In, has been shown to inhibit lymphocyte 
functions. LDL-In is isolated by precipitation with dextran sulfate, and the 
suppressive concentration, 27JUg/ml, is within the physiological range. 
Inhibition requires membrane binding (but not internalization) to a trypsin-
sensitive, saturable lymphocyte receptor. The binding is temperature-
sensitive and is increased by previous incubation of the cells in lipoprotein-
deficient serum and facilitated by Ca*2 ions. The receptor is not the LDL 
receptor. T8+ lymphocytes, the suppressor population, are the most sensitive 
to LDL-In suppression (210-214). Apo E from VLDL or LDL can suppress 
human and murine lymphocyte function. Chemically modified lipoproteins 
are not inhibitory, and all apo E isoforms are equally inhibitory. It has been 
shown to be the apo E protein, not the lipid moiety, that suppresses 
phaetohemagglutinin (PHA) induced increases in phospholipid turnover 
(215). Similarly, the delipidated fraction of inhibitory LDL (LDL-In) is just as 
active as the entire particle. LDL-In and apo E may be the same product. 
Results. As can be seen from figure 4-5, DS-LDL and LS/01 feeding 
strongly suppress secretion of a 33,000 M r band. The band still visible at 
33,000 may be a distinct protein, not apo E. In our hands the 33,000 M r 
protein is dramatically increased by Ac-LDL feeding. The effect of DS-LDL 
feeding on apo E secretion is examined further in Figure 4-6. As described 
above, the cells in this experiment were loaded with DS-LDL complexes 
prepared with one-tenth and one-one hundredth the amount of DS and the 
same amount of LDL. Reducing the amount of DS in the DS-LDL complexes 
almost restores apo E to control levels. 
This can be seen more clearly by immunoprecipitation of apo E, using 
a goat anti-human apo E serum, which fortunately also precipitated mouse 
apo E. Figure 4-7 shows that the protein is clearly induced by Ac-LDL 
feeding (lane B, Ac-LDL vs lane A, control). It is hardly visible from DS-LDL 
fed cells (lane C and lane E, identical samples), or LS/01 fed cells (Lane D). 
Expression of apo E returns in lanes F (DS-LDL, 0.1:1) and G (DS-LDL, 0.01:1) 
as the doses of DS in the DS-LDL are reduced. Takemura and Werb (196) 
reported the suppression of apo E secretion by endocytosis of DS. A similar 
mechanism may account for the decrease in apo E secretion by DS-LDL 
complex fed macrophages. 
Fibrinolysis 
Another macrophage function of great importance in the artery wall is 
protease secretion. Macrophages secrete several neutral proteases that are 
active in tissue remodeling and may be important for allowing the cell to 
Figure 4-7 
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Figure 4-7. Mouse macrophages were cultured for 2 days and then 
labeled with 35s-methionine for 4 hours. Secreted proteins were precipitated 
with goat anti-human apo E antiserum for 2 hours, then incubated with 
Protein A-agarose for an additional hour. Pellets were extensively washed 
and then resuspended in SDS sample buffer, loaded onto a 7-18% gradient 
SDS gel, electrophoresed and processed for autoradiography. Lane A, control; 
Lane B, Ac-LDL; Lane C and E, DS-LDL; Lane D, LS/01. Lane F, ceils fed DS-LDL 
complexes prepared with a 0.01:1 ratio of DS/LDL. Lane G, cells fed DS-LDL 
complexes prepared with a 0.1:1 ratio of DS/LDL. 
migrate. These enzymes are potentially very damaging, and their release is 
regulated. Johnson et al (142) have shown that ligands of the scavenger 
receptor trigger neutral protease release from mouse macrophages. Since 
foam cells are believed to migrate out of the fatty streak lesion (23-26) and 
plasminogen activator (PA) has an important role in cellular migration (216), 
w e were very interested to measure PA production in lipid-loaded 
macrophages, to see how lipid-loading would effect the release of neutral 
proteases. 
Plasminogen activator was first described in macrophages by 
Unkeless, Gordon, and Reich (160) as a 48 kd serine protease similar to the 
one produced by virally transformed fibroblasts. PA activity can be 
measured in cell lysates and in conditioned medium, or by plating the cells 
directly onto an 125l-labeled fibrin plate. PA production can be regulated by 
a variety of agents, acting both in vivo and in vitro. It is decreased by 
glucocorticoids, inhibitors of c A M P phosphodiesterase activity, and reagents 
that inhibit the macrophage microtubule network, colchicine or vinblastine 
(216-219). Increased PA activity is seen in macrophages elicited by 
intraperitoneal injection of thioglycollate broth or endotoxin. Thioglycollate-
or endotoxin-elicited macrophages can produce up to 100 times the PA of a 
resident unstimulated macrophage population (160). In vitro, P M A or Con A 
can act to increase cellular PA release (218). 
W e measured PA release by the highly sensitive fibrin plate assay 
(Figure 4-8; 160). Freshly isolated peritoneal cells were plated at 2 x 
lOVwell on 125l-fibrin coated wells. After 48 hours of culture in the 
presence of 100 ug/ml soybean trypsin inhibitor, the cells were washed and 
medium was replaced with M E M / 1 0 % Acid-treated FBS, serum that has had 
95% of its plasmin inhibitors inactivated by treatment with 1 N HC1. In time 
points measured to 22 hours, thioglycollate-elicited macrophages were 
shown to have potent proteolytic activity, degrading 38% of the substrate/ 5 
x 10 4 cells (data not shown). This was enhanced about two-fold by the 
addition of 10 ng/ml P M A to 55.5 % substrate solubilized/ 5 x 10 4 cells. 
Control M-10 resident macrophages without P M A stimulation degraded only 
8% of the fibrin layer, or 14% of the amount degraded by thioglycollate-
elicited cells. 
Both Ac-LDL and DS-LDL lipid-loaded macrophages were able to 
degrade 125l-fibrin; in fact, they appeared to be more active than the M-10 
cells. They degraded about 1.5 fold more 125l-fibrin than control cells. This 
increase was seen equally with and without P M A enhancement of 
degradation. DS-LDL fed macrophages treated with P M A actually equaled the 
degradative activity of an equal number of thioglycollate-elicited cells at 22 
hours. But the lipid-laden ceils retain the profile of resident cells by 
displaying a 5-10 hour lag between P M A addition and increased PA 
production. Thioglycollate-elicited macrophages, as shown in Figure 4-8 and 
in ref. 218, respond to P M A much faster, degrading 4 times as much as 
control cells at the earlier 10 hr timepoint, a difference cut in half by the 22 
hr determination. 
These results show that lipid-laden cells have increased protease 
activity above control macrophages. This could enhance their mobility and 
migration in the vessel wall and lead to tissue degradation. Like 
thioglycollate-elicited macrophages, foam cells are the result of chronic 
ingestion of particles. If lipid-laden cells are like thioglycollate-elicited cells, 
w e could expect to see equivalent increases in other protease activities, 
namely collagenase and elastase (188). In addition to allowing increased 











Figure 4r8. Mouse macrophages were cultured for 2 days on 1251-
fibrin coated wells in the presence of 100 jug/ml soybean trypsin inhibitor. 
The assay was started with fresh medium containing 100 ng/ml of the 
triggering agent. PMA. Aliquots were taken at the times indicated and the 
percent of substrate solubilized was determined per 5 x 104 cells after 
subtraction of background counts. Samples are as indicated. Data are the 
means t SEM for 6-9 samples. 
foam cell migration, active proteases in the vessel wall would certainly lead 
to damage to extracellular matrix proteins and increased inflammation. 
The increase in PA in Ac-LDL fed cells confirms the increase in neutral 
proteases observed by Johnson et al (142) after maleylated-BSA feeding. 
However, DS-LDL had not previously been shown to do this. 
H2O2 Release 
Reactive oxygen intermediates (ROD make up a potent part of the 
macrophage arsenal against invading microorganisms and tumor cells. The 
release of ROI can be stimulated by a variety of physiologic and non-
physiologic agents (170,220,221). The macrophage, once triggered, releases 
ROI into its milieu, sometimes damaging "innocent bystander" cells. As 
discussed in chapter 3, if the macrophage in the artery wall were releasing 
ROI, it could inactivate protease inhibitors, damage the extracellular matrix 
proteins, and even lead to cell death. Endothelial cells are particularly 
sensitive to ROI (222-224). Previously, w e showed that modified LDLs did 
not trigger H2O2 release from normal human monocytes and macrophages, 
with or without previous incubation with IFNy. However, the intracellular 
accumulation of lipids, possibly oxidized toxic lipids, could influence ROI 
release from macrophages, and since H2O2 could accumulate, it represents a 
particularly hazardous macrophage product. Accordingly, w e measured the 
release of H2O2 from lipid-laden cells (table 4-4). 
Without PMA, all cellular incubation conditions showed very similar 
low levels of H2O2 release. The control cells (M-10) showed an 80-fold 
increase, as expected, with the addition of the triggering agent, PMA. The 
PMA-triggered increase was similar for Ac-LDL ceils, 93-fold, but 
substantially reduced to only a 50-fold enhancement over no P M A for LS/01 
cells. In the case of DS-LDL fed cells, there was a major suppression of H2O2 
release triggered by PMA. H2O2 release was only 12 fold over no PMA, and 
only 15% of the M-10 plus P M A value. This dramatic decrease was dose 
dependent, as shown in table 4-5. 
Resident cells were incubated for 48 hours in the presence of DS-LDL 
complexes prepared as described above with 10-fold (0.1:1 DS/LDL) and 
100-fold (0.01:1 DS/LDL) less DS and equal amounts of LDL. A stepwise 
restoration of H2O2 releasing capacity was observed with the decrease in DS 
content. Ceils loaded with DS-LDL complexes released 26% of the H2O2 of 
control cells in these experiments. 0.1:1 DS/LDL complex-fed cells produced 
61% of control, and 0.01:1 DS/LDL-complex fed cells produced 81% of control. 
Cholesterol values for the samples fed reduced DS-content complexes were 
80% (0.1:1 DS/LDL) and 65% (0.01:1 DS/LDL) of the DS-LDL cholesterol value. 
or only 1.4-and 1.2-fold over control, compared to 2.5-fold for 1:1 DS-LDL 
loaded cells. 
The decrease in the cells' ability to release H2O2 did not appear to be 
due to a sequestration of P M A within lipid pools. In experiments testing 
H2O2 release in response to graded doses of the triggering agent, PMA, over 4 
logs, the DS-LDL fed cells showed the same pattern of release as control cells, 
but the magnitude at every point was dramatically reduced, reaching only 
35% of control at its maximum (Figure 4-9). 
Control experiments adding the H2O2 generating system of 
glucose/glucose oxidase to assays of H2O2 did not demonstrate scavenging of 
H2O2 by control or lipid-loaded cells, with or without P M A (data not shown). 
W e conclude from these experiments that lipid-loaded cells are still 
capable of releasing H2O2, although in DS-LDL cells the quantity is 
Table 4-4. Release of HgO? bv foam cells 
H2O2, nmol per mg of cell protein per hour* 
Culture condition -PMA +PMA 
M-10 6.8 + 0.8 556147 
Ac-LDL 4.3 ± 0.5 403 ± 42 * 
DS-LDL 6.4 + 0.5 79 ± 13a 
LS/01 6.4 ± 0.8 340 + 38 fc. 
* Mouse macrophages were cultured as described and assayed for H2O2 on 
day 2 of culture. P M A at 100 ng/ml was used as a secretagogue. Data are 
means ± SEM for 7 experiments, n= 2-3 coverslips per condition per 
experiment. Statistics are for each sample compared to control, a - P<.001, b 
-P<.01. 
Table 4-V RTfefl of dose of DS-LDL on Release of HgOg bv foam cells 
H2O2. nmol per mg of cell protein per hour* 
Culture condition -PMA +PMA 
M-10 4.6t 1.0 276 ±8 
DS-LDL (1:1) 5.2 + 0.2 73 + 7 
DS-LDL (0.1:1) 3.7 + 0.3 167 + 2 
PS-LPl (0.01;1) 2.9 t 0.4 224 + 22 
* Mouse macrophages were cultured as described and assayed for H2O2 on 
day 2 of culture. The ratio in parentheses signifies the proportion of DS to 
LDL in the complexes. P M A at 100 ng/ml was used as a secretagogue. Data 
are means + SEM. n- 3. 
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Figure 4-9. Mouse macrophages were cultured for 2 days and then 
H2O2 was determined as a function of the triggering agent, PMA. H2O2 assay 
was as described in methods. DMSO was added as a diluant control at a 
concentration equal to the highest concentration tested. Solid line, control 
cells. Dotted line. DS-LDL fed cells. Data are the means + SD for three samples. 
significantly reduced. However, w e do not believe that the increase in lipid 
content by itself can explain the reduction in H2O2 from DS-LDL fed cells, 
since Ac-LDL fed cells and LS/01 cells had similarly increased cholesterol 
levels and only slightly depressed H2O2 release. W e suggest that the cells' 
H2O2 release may be affected as a result of endocytosis of DS. Accumulation 
of the highly negative DS portion of DS-LDL was reported by Kielian and 
Cohn to be concentrated in the secondary lysosomes and inhibit phagosome-
lysosome fusion (140). DS is also known to reduce apo E secretion (196) and 
PA release (216). These results suggest that endocytosis of DS by the cells 
may suppress some cellular functions. Interestingly, thioglycollate-elicited 
macrophages also have a reduced capacity for H2O2 release, which has been 
attributed to ingestion of thioglycollate broth (225). Ongoing endocytosis of 
thioglycollate or DS-LDL complexes may compromise the macrophage's 
secretory abilities. These results suggested that other macrophage secretory 
products might be reduced in the foam cell. W e next examined the bioactive 
lipids, the metabolites of arachidonic acid. 
Arachidonic Acid Release 
25% of the membrane phospholipids of macrophages are arachidonic 
acid (20:4). Prostaglandin E2 (PGE2) is the most prominent metabolite of 
arachidonic acid in mouse macrophages. Prostaglandins have been shown to 
have potent effects including vasodilation, inhibition of lymphocyte 
proliferation and antibody production, edema, and pain. PGE2 in particular 
can increase phagocytosis and the number of Fc and Con A receptors on 
macrophages. The release of 20:4 from macrophages can be triggered by a 
variety of agents including zymosan, calcium ionophore A23187, immune 
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complexes, C. Parvum, LPS, colchicine, and EIgG. Different stimuli result in 
different magnitudes of release but a characteristic pattern has been 
established for resident cell populations (226). Inflammatory cells and 
activated cells show a different pattern of release (227). The release of PGE2 
correlates with the release by cells of acid hydrolases (190, 228). 
The 20:4 release and metabolites of lipid-laden macrophages were 
examined by labeling the cells with 3H-20:4 for 16 hr before assaying. This 
time allows the label to equilibrate in the cell. The low amount of 
spontaneous release of 3H-20:4 into the medium was not changed by lipid-
loading (Table 4-6). W h e n zymosan was used as a trigger, control cells 
released 27.6% of the 3H-20:4 label when assayed at 90 minutes, as reported 
in ref. 229. Although Ac-LDL fed cells showed little change from control, 
both LS/01 and DS-LDL fed cells showed a significant reduction in total 
release, to 79% of control for DS-LDL fed cells and only 41 % of control for 
LS/01 cells. W e also tested the effects of the calcium ionophore A23187, thus 
avoiding the phagocytic stimulus for release. Although the baseline values 
were higher in these experiments, the same reduction of 20:4 release in both 
LS/01 and DS-LDL fed cells occurred in response to ionophore (Table 4-7). 
W e were concerned that the lipid-loaded cells, having additional sinks 
for lipid, might not have as much 3H-20:4 available for release as the control 
cells. Dvorak et al have shown the incorporation of 3H-20:4 into intracellular 
lipid bodies in macrophages (230). Two-dimensional TLC revealed some 
differences in the cells' lipid profiles, as might be expected (Table 4-8). In 
control, Ac-LDL fed, and DS-LDL fed cells, more than 50% of the total 3H-20:4 
label was found in phosphatidyl ethanolamine and phosphatidyl choline, 
similar to the values Scott et al reported for resident peritoneal macrophages 
(158). LS/01 cells, however, have only 25% of their 3H-20:4 label in 
Table 4-6. Arachidonic acid release bv foam cells 
3H 20:4, % release at 90 min.* 
Culture condition - zym +zvm 
M-10 2.6 + 0.3 27.6 + 0.3 
Ac-LDL 3.3 +0.2 c 26.8+ 1.4c 
DS-LDL 2.6 +0.2 c 21.8+ 1.9 *> 
LS/01 1.7 10.2 £ 11.4+ 1.0 a 
* Mouse macrophages were cultured as described and labeled with 3H-20:4 
for 16 hours before assay for release on day 2 of culture. Zymosan was used 
at 160 jug/ml as a stimulant of release. Data are means + SEM for 5 
experiments, n» 2-3 samples per condition per experiment. Statistics apply 
to each sample compared to control, a = P<.001, b - P<.02. c - not significant. 
Table 4-7. Arachidonic acid release by foam cells 
3H 20:4, % release at 90 min.* 
Culture condition - A23187 +A23187 
M-10 2.9 + 0.1 39.8 ±0.1 
Ac-LDL 3.9 + 0.1 36.5 + 0.2 
DS-LDL 1.8 + 0.1 23.8 + 0.2 
LSZD1 2,1 ±0,4 19,6 ±0,1 
* Mouse macrophages were cultured as described and labeled with 3H-20:4 
for 16 hours before assay for release on day 2 of culture. Ionophore was 
used at 10 jug/ml as a stimulant of release. Data are means for n= 2 per 
condition. 
Table 4-8. 13H1 20:4 in foam cells 






* Mouse macrophages were cultured as described for 2 days and labeled 
with 3H-20:4 for 16 hours before use. Lipids were extracted and run on two 
dimensional TLC. 
phospholipids. LS/01 cells have twice as much label in the neutral lipid pools. 
These are probably intracellularly located, and therefore less available for 
release. In vivo, this partitioning of 20:4 and reduced release could change 
cellular interactions in the artery wall. 
Further analysis of the arachidonic acid profile of the lipid-loaded 
macrophages is shown in Table 4-9. Control macrophages released 2 7 % of 
their 3H-20:4 label as prostaglandin E2 (PGE2), as previously reported (229). 
The Ac-LDL fed cells and the DS-LDL cells hardly varied from that value. 
Unreacted 20:4 (control, 4%) and mono- and dihydroxy-eicosatetraenoic acid 
(Hetes; control, 6%) were as reported, and not significantly different in any of 
the lipid-loaded samples. However, LS/01 cells showed a relative shift in the 
cyclooxygenase pathway, resulting in an increase in PGE2 and a decrease in 
prostacyclin (PGI2) measured as its stable degradation product, 6-keto 
prostaglandin Fi~(6k-PGFj). PGI2. a potent vasodilator, was only 6 2 % of 
control in LS/01 cells. The relative increase in PGE2 does not result in an 
absolute increase, however, since these cells have such a reduced level of 
total release (shown again at far left of Table 4-9). 
Leukotriene C (LTC) was significantly depressed in Ac-LDL fed cells 
(50%) and LS/01 cells (85%). LTC, or slow-reacting substance of anaphylaxis. 
is a very potent vasoconstrictor, and its reduction generally correlates with 
markers of macrophage activation, like H2O2 release, or bactericidal activity 
(227, 231). LTC has been shown to promote endothelial cell PGI2 production 
(232). Reduced production of LTC, the vasoconstrictor, could result in 
reduced production of PGI2, the vasodilator, and greatly affect vascular tone 
in the artery. 
These studies do not include thromboxane, which is not a prominent 
product of mouse macrophages. However, it is the major arachidonic acid 
Table 4-9 Arachidonic acid metabolites released by foam cells 
[3H1 20:4. % released to zymosan at 90 min. * 
Condition (% rel) 6k-PGFj^ PGE? LTC Hetes 20:4 
M-10 27.6 31.4 27.0 23.2 6.2 4.2 
Ac-LDL 26.8 30.9 26.2 12.1 7.6 6.6 
DS-LDL 21.8 29.9 26.7 20.1 4.9 3-3 
LS/01 11.4 19.7 51.8 3.7 7.5 1.9 
* Mouse macrophages were cultured as described and labeled with [3H1 20:4 
for 16 hours before assay for release on day 2 of culture. Zymosan was used 
at 160 jug/ml as a stimulant of release. Macrophage culture medium was 
extracted and dried under N2 before HPLC as described in methods. Values 
are expressed as the percent of the total [3H] 20:4 products formed and 
calculated on the basis of discernable peaks above background, n-2 for LTC, 
Hetes. 20:4. n=l for PGE2. 6k PGF R. 
metabolite of fresh human monocytes, and it would be very interesting to 
examine the effects of lipid-loading on the human mononuclear phagocyte 
system (233). 
Interleukin 1 
To continue these studies, we evaluated another important class of 
proteins produced by macrophages, the growth factors. In particular, w e 
wanted to know about the secretion of interleukin 1. a monokine that 
regulates T lymphocytes and stimulates fibroblast growth and collagenase 
production (49, 50). II-1 also induces a 35% decrease in endothelial cell 
plasminogen activator production, and a 360% increase in production of a 
plasminogen activator inhibitor. As discussed in chapter 1, these changes 
reduce the fibrinolytic activity of EC and lead to an overall procoagulant 
state (48, 51-53). In light of these activities, and its reported ability to 
activate macrophages (54), II-1 could play an important role in the 
progression of the plaque. 
Measurements of II-1 were made using the D-10 cell line, a T 
lymphocyte clone which will proliferate in response to II-1 (164,165). 
Control cells (M-10 fed) produced approximately 1 U Il-l/ml of culture 
supernatant collected after 24 hours. No stimulation of D-10 cell growth was 
seen with cell-free medium. No stimulation of II-1 production was seen after 
the M-10 cells were incubated for 24 hours with 10 ng/ml PMA. But a 100-
fold enhancement of II-1 production was seen after 24 hours withl mg/ml 
LPS, as reported by Koide et al (164). In three experiments testing cell-free 
and cell-conditioned medium from lipid-fed macrophages, only slight 
variations in II-1 production were observed comparing the lipid-laden cells 
to control cells. Addition of conditioned culture medium at 10 times the 
highest concentration tested did not inhibit the response of the D-10 cells to 
recombinant II-1, suggesting that no inhibitor of II-1 was produced. 
Response to X Interferon 
The presence of T4+ lymphocytes in the fibrous cap of the 
atherosclerotic lesion (130,131) and the expression of the la antigen by SMC 
(132) suggest that the cytokine IFlty is present in the lesion. IFNy has 
pleiotropic effects on macrophages, and is called the macrophage activating 
factor (175). W e have seen that certain macrophage activities are reduced as 
a result of lipid loading. It is important to know the response of the lipid-
loaded macrophage to this regulatory factor. Preliminary experiments 
compared the effect of IFNy on cellular accumulation of Oil Red O-stainable 
material, and the ability of lipid-loaded cells to respond to IFNy by increasing 
expression of la antigens. Recombinant murine IFNy at 100 U/mi was added 
to the culture medium on day 0 or day 1 of culture, and cells were assayed 
for total cholesterol on day 3. The effect of IFNjj on lipid-loading can be seen 
in Figure 4-10. The cells were fixed on day 3 and stained for Oil Red 0 as 
before. Panel A shows cells that were loaded with Ac-LDL. They show the 
characteristic accumulation of Oil Red 0 staining material. The cells in B were 
loaded with Ac-LDL and IFfy. Panel C shows cells incubated for 1 day with 
IFIfy, and then for 2 days with IFNtf and Ac-LDL. Finally, D shows cells loaded 
with Ac-LDL for 1 day and then for two days with Ac-LDL and IFNx\ As can 
be seen from the photographs, the cellular accumulation of lipid droplets did 
not seem to be affected by IFN£ 
Sample . Figure 4-10 
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Lipid-laden cells were also plated in a 96-well plate with and without 
IFN$ and expression of the class II major histocompatability antigen, la, was 
determined in a cell ELISA (Birkeland and Pure, manuscript in preparation). 
While not a quantitative assay, the cell ELISA showed an increase in la 
expression after IFfy treatment. This increase was not affected by the order 
in which the cells received the cytokine and the lipid. These preliminary 
findings suggest that lipid-loaded cells were still able to respond to IFNjj, 
and did not show major differences in the lipid-laden cells' response as 
compared to that of control cells. W e plan to continue these studies to 
measure the release of H2O2 after IFNy treatment. Nathan et al (175) have 
shown that IFNx greatly increases the macrophage production of H2O2. This 
measurement should be particularly interesting in the case of the DS-LDL 
cells, which w e have shown have a substantially reduced release of H2O2. 
W e have seen that the three lipid-loading regimens produce Oil Red 0 
positive cells with significantly elevated cholesterol ester levels. The 
secretory functions of the cells have been altered in a complex way. 
Modulations do not appear to be due strictly to the cellular cholesterol level. 
Implications for the overall condition of the lipid-laden cells will be 
discussed in the next chapter. 
Figure 4-10. 40X photographs of Oil Red 0 stained mouse 
macrophages. Cells were cultured 3 days and then fixed in formalin and 
stained with Oil Red 0. Panel A. Ac-LDL cells. Panel B, cells incubated with 
Ac-LDL and IFN . Panel C, cells incubated with IFNy for 1 day and then 2 
days with Ac-LDL and IFNy. Panel D, cells incubated with Ac-LDL for 1 day 
and then 2 days with Ac-LDL and IFNy. 
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Chapter 5 Discussion and Conclusions 
W e have lipid-loaded macrophages to study the functions of foam 
cells. A number of reports have shown that macrophage functions are 
impaired as a result of interaction with lipid: cells are less cytotoxic (138), 
less endocytic (139), and have several of their activities depressed due to 
ingestion of polyanions (inhibited lysosome fusion, 140; inhibited PA release, 
196; reduced Apo E secretion, 216). Macrophage-derived foam cells have 
been touted as a lipid clearance system (23-26), but not enough is known 
about the lipid-loaded cells' capabilities to evaluate whether they can help 
alleviate inflammation and scavenge and dispose of excess cholesterol. 
To do these studies, w e selected three regimens for loading cells, each 
of which models known conditions from the artery. The lipids of the 
atherosclerotic plaque have been shown to be mainly cholesterol esters 
derived from LDL (74), modified LDL (114-118), LDL-GAG complexes (76-
79), and LDL bound to collagen and elastin (234). Lipoproteins or 
extracellular matrix proteins may also become modified in the artery after 
nonenzymatic attachment of glucose, as happens to proteins in diabetic 
patients (235). Diabetes is a risk factor for atherosclerotic disease. W e have 
incubated resident mouse peritoneal macrophages with combinations of 
lipids that model biologically-modified LDL, LDL-GAG complexes, and low 
serum HDL conditions. The resulting lipid-laden cells were characterized in 
an attempt to define functional capacities. 
Examination of the quantity and classes of the intracellular lipids of 
the lipid-laden cells shows that the predominant form of lipid accumulated 
by the cells is cholesterol ester (Figure 4-3, ref. 82,178). Similar proportions 
of increase in total cholesterol levels are quantitated by a fluorescent 
cholesterol assay and by direct extraction in dioxane of Oil Red 0 stained 
lipid droplets. 
Despite massive increases in cholesterol esters, the cells retain many 
features of macrophage function. They are still capable of Fc receptor-
mediated endocytosis-binding and ingestion of EIgG were quantitatively 
undiminished from control cells. Many of the cellular proteins are still 
produced after lipid-loading, as shown in Figure 4-4. Secreted proteins 
associated with endocytosis and lipid balance are altered, but many other 
macrophage secretory proteins remain unchanged (Fig 4-5). Of course, w e 
have loaded the cells for only two days, and foam cells in vivo may be 
exposed to lipid-loading for months or years. 
W e have shown that the lipid-laden cells are still capable of producing 
all the secretory products examined, including plasminogen activator, H2O2, 
arachidonic acid and its metabolites, PGE2, PGI2. LTC, and Hetes. The 
quantities of products are somewhat reduced in most cases, except for the 
release of plasminogen activator, which appears to be increased. 
The 20:4 metabolites regulate vascular tone and inflammation in the 
artery wall. The macrophages. EC, SMC, and platelets all produce these 
agents, which can then act on the neighboring cells. The large number of 
studies in this area reflect the complexity of these interactions in the artery. 
For example, leukotrienes have been shown to mediate leukocyte adhesion 
to endothelium (236), and to promote endothelial cell PGI2 production (232). 
LDL has been reported to stimulate PGI2 and PGE2 production from S M C in 
culture (237). The macrophage product II-1 induces PGI2 synthesis in EC and 
SMC (238). Macrophages make platelet activating factor, which can lead to 
platelet aggregation and release of 20:4 metabolites as well as PDGF (239). 
Such results in vitro, however, can only provide information about the 
abilities of the cell types and the mediators, not about their interactions in 
vivo. At present, clarifying abilities is all w e can do, since w e do not have a 
successful in vitro model for all the aspects of cell involvement in the artery 
wall. 
W e plan to continue these studies to measure the effect of lipid-
loading on macrophage production of tumor necrosis factor, TNF. Activated 
macrophages produce TNF (56). In addition to causing regression of some 
tumors, acting as a growth factor for fibroblasts, and suppressing 
anticoagulant activity on the endothelial cell surface (57, 58), TNF has 
metabolic effects on lipid balance, inhibiting lipogenic enzymes in adipocytes 
(240). TNF and IL-1, while having some overlapping functions, have 
independent regulation which results in a variety of effects (47). The lack of 
observed change in IL-1 production from lipid-laden cells does not predict 
the effects of lipid-loading on TNF release. 
Our initial attempts to determine if the release of TNF was altered 
after lipid-loading of macrophages were unsuccessful for technical reasons. 
W e measured cell death after incubation with conditioned medium from 
control and lipid-loaded cells. The results with the bioassay showed that the 
culture medium itself was toxic to the target cells, probably due to the high 
concentration of lipids. W e have set up a collaboration to pursue the 
determination of TNF by western blot analysis. 
Another factor that has a large role in the artery wall is PDGF: it is 
chemotactic for monocytes (43). fibroblasts and for SMC. as well as mitogenic 
for fibroblasts and for S M C (29-31). Macrophages make a PDGF-like factor 
after stimulation by various agents (32. 33). The possible effects of lipid-
loading in the macrophage are unknown. W e plan to measure PDGF 
production by lipid-laden cells. As was the case for TNF, our initial 
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measurements of PDGF by bioassay were inconclusive for technical reasons 
and w e will pursue the determination of its production by lipid-loaded cells 
with other techniques. 
To conclude: w e have described an in vitro model system for foam 
cells and characterized the cells. W e have shown that the cells maintain their 
capacity for all the macrophage functions examined, with some variations in 
quantities of products produced. W e have begun studies on another very 
important class of proteins, the growth factors, and would like to pursue this 
model to evaluate possible changes in migration through intact endothelial 
cell monolayers, chemotaxis, and changes in function after longer periods of 
lipid-loading. In addition, it would be of interest to examine these questions 
in the human foam cell, with autologous LDL. 
The macrophage that enters the artery wall has been studied 
extensively with respect to what products it can elaborate and under which 
circumstances. The effects of these agents are also under close scrutiny. The 
conditions in the artery dictate that the cells will become lipid-loaded. W e 
know how much and how quickly macrophages ingest various types of lipids. 
W e also know that certain types are not easily digested (140,157) and 
remain inside the cell for long periods. W e have shown that in many respects 
lipid-laden cells maintain macrophage functions after lipid-loading. But the 
decreased production of H2O2 and 20:4 show that inflammatory mediators 
are somewhat reduced. While it is difficult to predict what changes in the 
macrophage's large repertoire would occur in vivo, w e may speculate that 
the foam cell is not "activated" in the defined sense (241). It may be more 
like an inflammatory macrophage, like the model thioglycollate-elicited 
macrophage. Or it may be simply a resident cell which after much abuse by 
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lipid-loading has become sluggish in its functions. The details of the foam 
cell's abilities remain to be determined. 
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